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Abstract: The sea is a rich source of biological active compounds, among which
terpenyl-quinones/hydroquinones constitute a family of secondary metabolites with diverse
pharmacological properties. The chemical diversity and bioactivity of those isolated from marine
organisms in the last 10 years are summarized in this review. Aspects related to synthetic approaches
towards the preparation of improved bioactive analogues from inactive terpenoids are also outlined.
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1. Introduction
Terpenyl-quinones/hydroquinones (TQs/THQs) constitute a family of mixed biogenesis
metabolites widespread in nature, either as primary or secondary metabolites in many organisms.
Compounds like vitamin K, tocopherols, ubiquinones, or plastoquinones belong to this family,
and they play important roles in oxidative metabolism, such as in electron transport chain or in
photosynthesis [1]. Many other TQs/THQs have been isolated from different sources, and they are
often referred as meroterpenoids because of their biosynthesis through a mixed polyketide-isoprenoid
pathway. A wide variety of biological activities has also been described for them, mainly cytotoxic
and antioxidant properties that are been related with their involvement in redox cycling and/or
Michael-1,4-addition reactions. Those quinone derivatives with a unique biosynthetic origin,
either from a polyketide or isoprenoid pathway, are not considered in this revision.
Many of those metabolites were isolated from marine organisms, such as brown algae and sponges,
and these have been covered by previous specific reviews, which were mainly organized according the
source organism [1–6]. In this review, we focus on the structure and bioactivity of TQs/THQs of marine
origin described along the last 10 years (January 2008–April 2018). They have been organized according
the size and type of the terpenoid fragment, ranging from simple isoprene units to large terpenoids,
and according the size and nature of the quinone moiety, with most of them being p-benzoquinone
(BQ)/1,4-hydroquinone (HQ) derivatives. Often, they have varied carbon skeletons originating from
intermolecular cyclizations and/or rearrangements of the initial terpenoid precursors, leading to
unique cyclic structures. We consider aspects related not only with their structure or marine source,
but also with their biological properties, and in some cases with those synthetic approaches towards
the natural products and/or their bioactive analogues. It should be noted that the numbering used
for these compounds is not uniform; sometimes the terpenoid part is numbered as usual and the
polyketide core with primes, and other times, the quinone fragment is numbered as a continuation of
the terpenoid system or even the other way around. Due to the difficulties that unifying it could cause,
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we decided to keep the numbering system used in the original articles, indicating in the figures those
positions that are mentioned in the text.
2. Meroterpenoids with Simple Isoprene Units
Few examples of simple meroterpenoids, with only one or two isoprenyl units, have been
described since the initial isolation of the isoprenylquinone 1, HQ 2, and the chromenol 3 (Figure 1)
from the ascidian Aplidium californicum in the late 1970s [7]. They were covered in a previous review [3]
but in addition to the previously reported cytotoxic properties [7], the anti-inflammatory activity of
1 had been described more recently, after its isolation from fresh specimens of Aplidium sp. collected
near Leigh Harbor, New Zealand [8].
Several bis-isoprenyl HQ derivatives, comosusols A–D (4–7), and the diprenylated quinone 8
(Figure 1) were isolated from the brown algae Sporochnus comosus [9]. They were screened for their
cytotoxic activities against the four human tumor cell lines MCF-7 (breast), SF-268 (central nervous
system), H460 (lung), and HT-29 (colon), and on normal mammalian cells CHO-K1 (Chinese hamster
ovary). All of them were cytotoxic in the µM range, with 5 being the most potent, with GI50 values
between 5 and 6 µM against the panel of cell lines tested [9].
The same diprenylated quinone 8 was described by the first time from the New Zealand brown
alga Perithalia capillaris and it was efficiently synthesized by Moody using two consecutive Claisen
rearrangements that proceeded with both high chemo- and regioselectivity [10].
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Figure 1. Structures of meroterpenoids with simple isoprenyl units. 
An example of a naphthoquinone (NQ) of marine origin with only one isoprenyl group is 
3-chloro-6,8-dihydroxy-α-lapachone (9) (Figure 1), a new natural compound isolated from the 
marine-derived Streptomyces sp. SCSIO 10428, obtained from a sediment sample collected from 
Xieyang Island, China [11]. 
3. Meroterpenoids with Open-Chain and Cyclic Monoterpenoids 
Meroterpenoids with a monoterpenyl unit were isolated from diverse marine organisms, either 
as HQ or as quinone derivatives. In addition, the original geranyl chain can be as such with different 
oxidation degrees, or it can be cyclized, forming carbocycles and/or chromene systems by 
ring-closure between one of the phenolic groups of the HQ and a double bond of the terpenoid. 
From the green alga Cymopolia barbata, collected at the northeastern coast of Jamaica, a new 
cymopol type metabolite that did not contain a bromine atom, debromocymopolone (10), was 
isolated together with the previously identified brominated compounds cymopolone (11), 
3-hydroxycymopolone (12), 7-hydroxycymopolone (13), 3,7-dihydroxycymopolone (14), cymopol 
monomethyl ether (15) and 7-hydroxycymopochromanone (16) [12] (Figure 2). 
Figure 1. Structures of meroterpenoids with simple isoprenyl units.
An example of a naphthoquinone (NQ) of marine origin with only one isoprenyl group is
3-chloro-6,8-dihydroxy-α-lapachone (9) (Figure 1), a new natural compound isolated from the
marine-derived Streptomyces sp. SCSIO 10428, obtained from a sediment sample collected from
Xieyang Island, China [11].
3. Meroterpenoids with Open-Chain and Cyclic Monoterpenoids
Meroterpenoids with a monoterpenyl unit were isolated from diverse marine organisms, either as
HQ or as quinone derivatives. In addition, the original geranyl chain can be as such with different
oxidation degrees, or it can be cyclized, forming carbocycles and/or chromene systems by ring-closure
between one of the phenolic groups of the HQ and a double bond of the terpenoid.
From the green alga Cymopolia barbata, collected at the northeastern coast of Jamaica,
a new cymopol type metabolite that did not contain a bromine atom, debromocymopolone (10),
was isolated together with the previously identified brominated compounds cymopolone (11),
3-hydroxycymopolone (12), 7-hydroxycymopolone (13), 3,7-dihydroxycymopolone (14), cymopol
monomethyl ether (15) and 7-hydroxycymopochromanone (16) [12] (Figure 2).
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benzo[c]chromene-7,10-dione scaffold, which was particularly rare among natural products [13]. In 
terms of biogenesis, it seemed reasonably that they proceeded via dimerization of 
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2-geranyl-6-methoxyhydroquinone with oxygen in pyridine [14]. 
 
Figure 3. Structures of Aplidium meroterpenoids 17–24. 
Chromenol 18, HQ-sulfate 19, and scabellone B (21) were found to have anti-inflammatory 
activity mediated by inhibition of neutrophil superoxide production [13], activity that was also 
detected for the simple HQ 24 (Figure 3), isolated from fresh specimens of New Zealand ascidian 
Aplidium sp. [8]. Scabellone B (21) was also evaluated against the parasites Trypanosoma brucei, 
Trypanosoma cruzi, Leishmania donovani, and Plasmodium falciparum, showing certain selectivity 
Figure 2. Cy opol type eroterpenoids isolated fro Cymopolia barbata.
Copp et al. isolated and identified several new and known BQ/HQ derivatives, with a geranyl
substituent, from the ascidian Aplidium scabellum, collected at Rabbit Island in New Zealand [13].
Among the known metabolites were verapliquinone A (17) and the chromenol 18 (Figure 3), which were
identified in the same extract fraction as the new compound 2-geranyl-6-methoxy-1,4-HQ-4-sulfate
(19). The next fractions contained a family of new pseudodimeric meroterpenoids, named scabellones
A–D (20–23) (Figure 3). Scabellone A (20) contained a 5-substituted chromenol fragment, while the
others contained a benzo[c]chromene-7,10-dione scaffold, which was particularly rare among natural
products [13]. In terms of biogenesis, it seemed reasonably that they proceeded via dimerization of
2-geranyl-6-methoxybenzoquinone and/or 2-geranyl-6-methoxyhydroquinone, and in fact, the same
authors performed a biomimetic dimerization synthesis of scabellones A and B starting from
2-geranyl-6-methoxyhydroquinone with oxygen in pyridine [14].
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Figure 3. Structures of Aplidium meroterpenoids 17–24.
Chromenol 18, HQ-sulfate 19, and scabellone B (21) were found to have anti-inflammatory activity
mediated by inhibition of neutrophil superoxide production [13], activity that was also detected for
the simple HQ 24 (Figure 3), isolated from fresh specimens of New Zealand ascidian Aplidium sp. [8].
Scabellone B (21) was also evaluated against the parasites Trypanosoma brucei, Trypanosoma cruzi,
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Leishmania donovani, and Plasmodium falciparum, showing certain selectivity towards P. falciparum with
IC50 4.8 µM, and low cytotoxicity on a L6 rat myoblast cell line (IC50 65 µM) [13].
Other meroterpenoids containing a benzo[c]chromene-7,10-dione scaffold were
thiaplidiaquinones A and B (25 and 26) (Figure 4), which bore an additional dihydrothiazine-fused
ring. Since they were reported in 2005 by Fattorusso et al. [15], several studies dealing either with
their synthesis or their biological evaluation had been published. They were isolated from the
Mediterranean ascidian Aplidium conicum, collected at Sardinia (Italy) and almost simultaneously,
interesting biomimetic syntheses of thiaplidiaquinones were published by Moody et al. [16] and Copp
et al. [17]. Moody used a facile oxa-6π-electrocyclic ring closure reaction starting from simple phenolic
precursors, followed by installation of the 1,4-thiazine-dioxide ring by reaction with hypotaurine,
while Copp used a base-mediated dimerization of geranylbenzoquinone, followed also by addition
of hypotaurine.
The thiaplidiaquinones A and B (25 and 26) were initially described as cytotoxic, inducing
apoptosis by a mechanism that involved the production of intracellular reactive oxygen species
(ROS) [15]. More recent studies showed that these natural compounds were weak inducers of ROS
in Jurkat cells, while the synthetic precursors 28 and the dioxothiazine regioisomers 33 were more
potent inducers [18] (Figure 4). The non-natural regioisomers were also more potent in the US-NCI
tumor cells panel, with selectivity towards melanoma cell lines, and more active in antiplasmodial
assays than the natural compounds. In the same study, it was found that the positioning of the geranyl
side chain influences the mechanism of Jurkat cell death. Thus, analogues of thiaplidiaquinone A
caused death dominantly by necrosis, while thiaplidiaquinone B analogues caused cell death via
apoptosis [18]. The same authors synthesized a series of analogues (27–34) (Figure 4) modifying the
length of the prenyl chains. In fact, they obtained isoprenyl and farnesyl series and compared their
bioactivity with the geranyl series. They found that isoprenyl and farnesyl series were more potent
than the geranyl series against P. falciparum; however, the geranyl series were better as inhibitors of the
farnesyltransferase enzyme [19].
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From the same ascidian A. conicum collected at Porto Cesareo, Italy, two thiazinoquinones were
isolated, conithiaquinones A and B (35 and 36) (Figure 5). They have an uncommon linearly 6,6,5-ring
skeleton with a dioxothiazine-fused ring, and showed an interesting cytotoxicity against MCF-7 human
breast cancer cells. Other known meroterpenoids isolated from this species were conicaquinones A
and B (37a and 37b), and chromenols 39 and 40 [20] (Figure 5). To deepen into the mechanism of action
of these secondary metabolites, four thiazinoquinones: thiaplidiaquinone B (26), conithiaquinones A
and B (35 and 36), and conicaquinone A (37a) were subjected to voltammetric studies, with the finding
that all of them were able to form semiquinone radical species which, depending on the protonation
state, could be reduced or oxidized in the presence of redox-active components such as O2 and ROS,
suggesting that their cytotoxic potency would be related to their ability for reduction and generation
of radical species [21]. The same authors related not only this ability to form semiquinone species,
but also a strong interaction with free Fe(III)-protoporphyrin IX with the high antiplasmodial activity
showed by several alkyl analogues of aplidinones A–C (38a–c), which were other thiazinoquinones
with a geranyl chain, previously isolated from A. conicum [2,22].
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Epiconicol (40) was first isolated from the ascidian Aplidium aff. densum, together with
didehydroconicol (41) and methoxyconidiol (42) (Figure 5), and they are examples in which the
original geranyl chain was cyclized to a menthane [23]. These compounds and their monomethylated
derivatives 43–45 (Figure 5) were easily synthesized from 1,4-HQ or 4-methoxyphenol and citral,
and then they were evaluated as antibacterial against Escherichia coli and Micrococcus luteus, and as
an antiproliferative against sea urchin eggs and a panel of cancerous and normal cells [24]. It was
found that only 40 and 41 were weakly active in the antibacterial assays. In the antiproliferative assays,
methoxyconidiol (42) showed the best results at the µM level, while the methylation of a phenolic
group produced a total loss of activity in all of them [24].
Pseudoalteromone A (46) (Figure 6), was a new ubiquinone analogue isolated from a marine
bacterium Pseudoalteromonas sp., originally isolated from a cultured-type octocoral Lobophytum crassum,
from the National Museum of Marine Biology and Aquarium in Taiwan. It had an uncommon
nor-monoterpenoid moiety, probably formed by degradative oxidation of a methylidene group
in the monoterpenoid chain. It exhibited significant cytotoxicity towards four tumoral cell lines
(IC50 = 3.7–9.5 µg/mL), and also displayed a significant inhibitory effect on the elastase release by
human neutrophils, an assay to predict anti-inflammatory activity [25].
Studies on the cultured soft corals Sinularia flexibilis and Lobophytum hsiehi from the same Museum
in Taiwan, led to the isolation of flexibilisquinone (47) (Figure 6), another ubiquinone analogue with a
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methyl ester function on the monoterpenoid moiety [26]. It also displayed in vitro anti-inflammatory
effect by inhibiting the accumulation of the pro-inflammatory iNOS and COX-2 proteins of the
LPS-stimulated RAW264.7 macrophage cells [26].Mar. Drugs 2018, 16, x FOR PEER REVIEW  6 of 52 
 
 
Figure 6. Structures of the quinone meroterpenoids 46–48. 
Not only BQ meroterpenoids have been identified from marine organisms, but there are also 
diverse NQ derivatives. One simple example of this kind is scabellone E (48) (Figure 6), a NQ 
derivative that was first obtained during the biomimetic cyclization of 
2-geranyl-6-methoxyhydroquinone, and which was identified later as a natural compound in the 
extract of A. scabellum [14]. 
Other NQ meroterpenoids are naphthablins A–C (49–51) (Figure 7), which were identified from 
a marine strain of actinomycete, Streptomyces sp. CP26-58, isolated from the marine sediment 
collected at the San Francisco Bay, California. They exhibited weak HeLa cell growth inhibition [27]. 
From a very close marine strain Streptomyces sp. CNQ-509 isolated also from a marine sediment 
collected off La Jolla, California, two new NQ-based meroterpenoids were identified and named 
naphterpins D and E (52–53) (Figure 7). In these NQs, the monoterpenoid chain was modified by 
cyclization and hydroxylation. Compounds 52 and 53 exhibited free radical scavenging activity [28]. 
 
Figure 7. Structures of naphthablins and naphterpins 49–53. 
A NQ derivative with geranyl and isoprenyl chains, A80915G-8′′-acid 54 (Figure 8), was 
identified from the Streptomyces sp. MS239, a marine-derived Streptomyces strain isolated from saline 
mud collected at Tokushima, Japan, that presented mevalonate pathway genes. This compound 
showed weak antibacterial activity against Bacillus subtilis (MIC 64 μg/mL) and it was inactive to 
Staphylococcus aureus and Enterococcus faecium [29]. In extracts from the same strain, other related 
known meroterpenoids such as A80915G (55), naphthomevalin (56) (Figure 8), and 
napyradiomycins A1 and B1 (59 and 65) (Figure 9) were also identified. These halogenated 
meroterpenoids were prenylated at C-2 and C-3 of the naphthalene core, which was an unusual 
substitution pattern from a biosynthetic point of view; only recently have Moore et al. reported two 
enzymes that are responsible for the prenylation and an α-hydroxyketone rearrangement that 
explained such a pattern [30,31]. The same authors performed a biomimetic total synthesis of 
naphthomevalin via a thermal α-hydroxyketone rearrangement, which supported the pathway [30]. 
Figure 6. Structures of the quinone eroterpenoids 46–48.
Not only BQ meroterpenoids have been identified from marine organisms, but there are also
diverse NQ derivatives. One simple example of this kind is scabellone E (48) (Figure 6), a NQ derivative
that was first obtained during the biomimetic cyclization of 2-geranyl-6-methoxyhydroquinone,
and which was identified later as a natural compound in the extract of A. scabellum [14].
Other NQ meroterpenoids are naphthablins A–C (49–51) (Figure 7), which were identified from a
marine strain of actinomycete, Streptomyces sp. CP26-58, isolated from the marine sediment collected
at the San Francisco Bay, California. They exhibited weak HeLa cell growth inhibition [27]. From a
very close marine strain Streptomyces sp. CNQ-509 isolated also from a marine sediment collected off
La Jolla, California, two new NQ-based meroterpenoids were identified and named naphterpins D
and E (52–53) (Figure 7). In these NQs, the monoterpenoid chain was modified by cyclization and
hydroxylation. Compounds 52 and 53 exhibited free radical scavenging activity [28].
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NQ derivative with geranyl and isoprenyl chains, A80915G-8′ ′-acid 54 (Figure 8), was identified
from the Streptomyces sp. MS239, a marine-de iv d Streptomyces strain isolated from saline mud
collected at Tokushima, Japan, that presented mevalonate pathway genes. This compound sh we
weak antibacterial activity against Bacillus subtilis (MIC 64 µg/mL) and it was in ctive to Staphylococcus
aureus and Ente ococcus faecium [29]. In extracts from the sa e strain, other related known
meroterpenoids such as A80915G (55), naphthomevalin (56) (Figure 8), and napyradiomycins A1
and B1 (59 and 65) (Figure 9) were also identified. Th se halogenated meroterpenoids were prenyl t
at C-2 and C-3 of the naphthalene core, which was an unusu l substitution pattern from a biosy thetic
point of view; only recently have Moore et al. reported two enzymes that are r sponsible for the
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prenylation and an α-hydroxyketone rearrangement that explained such a pattern [30,31]. The same
authors performed a biomimetic total synthesis of naphthomevalin via a thermal α-hydroxyketone
rearrangement, which supported the pathway [30].Mar. Dru s 2018, 16, x FOR PEER REVIEW  7 of 52 
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Napyradiomycins (NPD) are a family of natural halogenated meroterpenoids that are produced
by diverse marine-derived Streptomyces strains. These natural secondary metabolites bear an isoprenyl
and a geranyl chain on the NQ core, forming additional cycles. Since the isolation of the first NPD
in the 1980s from the actinomycete Chainia rubra, which was later reclassified as Streptomyces ruber,
nearly 50 different NPDs have been described [32]. The nomenclature used for these compounds in
the literature is very complex, and sometimes includes the strain number and molecular weights,
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and sometimes other numbers and letters, etc. that make it difficult to follow them properly. All of the
NPDs have the isoprenyl unit cyclized on the NQ core, forming an additional benzochromene system.
The monoterpenoid chain was a linear substituent in the “A-type” NPDs, a cyclic monoterpenoid
substituent in “B-type” NPDs, and it constitutes a monoterpenoid bridge between both rings of the
NQ core, forming a 14-membered ring in “C-type” NPDs (Figure 9).
From the marine-derived Streptomyces sp. SCSIO 10428, isolated from a sediment sample collected
from Xieyang Island, China, two new A-type NPDs 57 and 58 were isolated, along with the known
A-type NPDs 59 and 60, two known B-type NPDs 64 and 65, one known C-type NPD 72 (Figure 9),
the known naphthomevalin 56 (Figure 8), and 3-chloro-6,8-dihydroxy-α-lapachone (9) (Figure 1),
mentioned above [11]. NPDs 57, 59 and 3-chloro-6,8-dihydroxy-α-lapachone were also isolated from
a cultured marine-derived Streptomyces sp. CA-271078, isolated from an ascidian collected at Sao
Tome, Sao Tome and Principe, along with a new B-type NPD 66 [11,32] (Figure 9). Two B-type
NPDs 62 and 63 and four C-type NPDs 70–73 (Figure 9) were identified from two marine-derived
Streptomyces sp. CNQ-329 and CNH-070 isolated from a marine sediment sample collected at San
Diego, California [33], while the strain CNQ-525 isolated from a similar marine sediment sample
collected at La Jolla, California, yielded one brominated A-type NPD 61 and three B-type NPDs,
67–69 [34] (Figure 9).
In general, NPDs exhibit diverse bioactivities, particularly antibacterial. Most of the NPDs
described above demonstrated potent bactericidal activity against contemporary methicillin-resistant
S. aureus strains, particularly those of the A- and B-type, being those of the C-type are less potent
compounds [11,32,33,35]. Some of them were tested for their antifungal activity, although none of them
were active [32], and also for their cytotoxicity against several tumor cell lines, with the finding that they
were cytotoxic at the µM level, being able to induce apoptosis in a dose-dependent manner [11,33,34].
4. Meroterpenoids with Open-Chain and Cyclic Sesquiterpenoids
Meroterpenoids that incorporate a sesquiterpenoid moiety are a wider group of TQs/THQs from
marine origins. The sesquiterpenoid can be open-chain or can undergo intramolecular cyclization
and/or rearrangements of the original farnesyl chain to form either monocyclic or polycyclic cores.
Thus, they can have a wide variety of sesquiterpenoid skeletons.
4.1. Open-Chain Sesquiterpenoids
In this section, compounds with a non-cyclic farnesyl chain are considered together with the
corresponding chromene derivatives resulting from the cyclization of the acyclic sesquiterpenoid on
the aromatic fragment.
From an ascidian Aplidium sp. collected at Ross Sea, Antarctica, an oxygenated derivative of the
farnesyl HQ, rossinone A (74) (Figure 10), was isolated. It showed in vitro anti-inflammatory activity
acting as suppressor of superoxide production rather than as superoxide scavenger; it also exhibited
modest antimicrobial, antifungal, and antiviral activities against B. subtilis, Trichophyton mentagrophytes,
and HSV-1 respectively [8].
Two new chromenol derivatives, nitrosporeunols E and F (75 and 76), were isolated from
the mutated marine-derived strain of Arctic Streptomyces nitrosporeus YBH10-5, along with
the known 2-farnesyl-5-methylhydroquinone (78), 2-farnesyl-5-methylbenzoquinone (79),
and deacetoxyyanuthone A (81) (Figure 10). They were tested as antihyperlipidemics, and it
was found that only 79 was a potent lipid-lowering agent, which decreased lipid levels through
upregulation of the PARPα pathway in HepG2 cells. This kind of activity is rarely reported for extracts
of marine microorganisms [36]. Deacetoxyyanuthone A (81) was also found in the fungus Gliomastix
sp. ZSDS-F7, isolated from the sponge Phakellia fusca from Yongxing Island of Xisha, along with
deacetylyanuthone A (82) and hydrodeacetoxyyanuthone A (83) (Figure 10). They showed significant
cytotoxicity against different cancer cell lines and, in addition, hydrodeacetoxyyanuthone A (83)
exhibited antimycobacterial activity [37].
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The regioisomer of 79, 2-farnesyl-6-methylbenzoquinone (80), and the new chromenol 77 were
isolated from the brown alga Homoeostrichus formosana, collected off the coast of San-Hsian-Tai, Taiwan.
They had moderate cytotoxicity against three cancer cell lines, and good antibacterial activity against
Pseudomonas aeruginosa; i addition, fa nesylmeth lbenzoquinon 80 was f und to display potent
in vitro anti-inflammatory activity by inhibiting superoxide an on formation [38].
New sulfated HQs, siphonodictya s E1–E4 (84–87) (Figure 11), were isolated from the Caribbean
spo ge Aka coralliphag m collected off the coast of San Salvador, Baha as. Compounds 84 and 85 bore
the sesquit rpene chain oxidized at one of the terminal methyl groups, and 86 had t o sulfated ester
groups. For siphonodictyal E4 (87), the structure shown in Figure 10 was proposed, although it could
not be unambiguously assigned. In addition to a chromane, it contained a 15-membered macrocycle
probably formed by an aldol addition from a precursor with an acyclic sesquiterpenoid that was
partially oxidized at its end. All four derivatives were evaluated for their cytotoxicity and antibacterial
activities, and it was found that only 86 showed mild activity against Gram-positive bacteria, and none
of them were cytotoxic, neither did any have any effects on Gram-negative bacteria [39].
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Only two examples of meroterpenoids with an open-chain sesquiterpenoid attached to a NQ
core have been described in this period. They are merochlorins C and D (88 and 89) (Figure 12),
produced by the marine bacterium Streptomyces sp. strain CNH-189, isolated from a marine sediment
sample collected near Oceanside, California [40]. They had a sesquilavandulyl skeleton, an unusual
rearranged C15-isoprene unit that is present in bacteria, whose biosynthesis was mediated by a
vanadium-dependent chloroperoxidase Mcl24 that has been recently characterized [30].
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There were several methylated toluquinols, cystoazorones [41] and cystodiones [42], isolated
from brown algae of genus Cystoseira that had a 14-carbon chain. Initially, they seemed to be
nor-sesquiterpenoids, however, it is more probably that they came from the degradation of a
diterpenoid unit, as suggested by the authors and so, they are presented later in Section 5.
4.2. Monocyclic Sesquiterpenoids
In the period covered by this review, few meroterpenoids with a monocyclic sesquiterpenoid unit
were described. That was the case of metachromins U, V, and (90–92) (Figure 13), isolated from the
marine sponge Thorecta reticulate collected off Hunter Island, Tasmania. All three compounds had the
same terminal cyclohexane moiety, but they differed at the other end of the sesquiterpenoid. hile 90
was a chromene derivative, 91 was a HQ and 92 had an additional C–C bond between the aromatic
part and the terpenoid forming a NQ moiety. Metachromins U- were found to be cytotoxic against
several cancer cell lines, with 91 being the most potent and 92 the less active [43]. Other previous
metachromins were compiled in the chapter of de Rosa and Tommonaro [1].
From the marine-derived Streptomyces niveus SCSIO 3406 isolated from a South China Sea
sediment, several sesquiterpenoid NQs were identified and named marfuraquinocins A–D (93–94)
(Figure 13), which differ in the stereochemistry at C-13 and in presence or absence of a hydroxyl group
at C-11. All of them showed significant cytotoxic and antibacterial activities [44]. Another cytotoxic
and antibacterial furonaphthoquinone with a different rearranged monocyclic sesquiterpenoid side
chain is neomarinone (95) (Figure 13); it was isolated previously from a fermentation broth of the
marine-derived actinomycete CNH-099, but its stereochemistry remained unknown until its total
synthesis in 2009 by Pérez-Sestelo et al. [45]. Another member of the marinone family with a different
cyclization pattern on the sesquiterpenoid moiety is debromomarinone (96) (Figure 13), which while
known since the 1990s, it has been recently isolated from the marine strain of actinobacterium
Streptomyces sp. CNQ-509 [28].
Capilloquinol (97) (Figure 14) is a HQ with an unprecedented skeleton isolated from the soft coral
Sinularia capillosa collected at Dongsha Atoll, Taiwan. It had a 12-membered ketalized macrocycle
derived from the farnesyl chain. It was cytotoxic against the mouse leukemia P-388 but it did not show
appreciable cytotoxicity against A-549 and HT-29 cells, nor was it active against human pathogenic
cytomegalovirus [46].
A different cyclization pattern was found in 2,3-didehydro-19α-hydroxy-14-epicochlioquinone B
(98) (Figure 14), in which a monocyclic terpenoid configured a to tetracyclic system that included two
fused chromenoid systems. It was isolated from the fungal strain Nigrospora sp. MA75, obtained from
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the Chinese marine semi-mangrove plant Pongamia pinnata, and it showed antibacterial and cytotoxic
activities [47].Mar. Drugs 2018, 16, x FOR PEER REVIEW  11 of 52 
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4.3. Bicyclic Sesquiterpenoids
This is the largest group of merosesquiterpenoids that are considered in this review. Most of them
have a bicyclic terpenoid, derived from a drimane or a rearranged drimane skeleton. Marcos et al. [6]
performed a good compilation of this type of compounds and proposed the name of aureane and
avarane for those that biogenetically arise from the drimane skeleton by one and two methyl migrations.
Later, de Rosa and Tommonaro [1] added the names bolinane, peyssonane, and frondosinane for
compounds with different rearrangements of the sesquiterpenoid skeleton, and also Jiao et al. [48]
proposed the name of dysidavarane for an unprecedented carbon skeleton, which includes all the
terpene and quinone atoms of the whole meroterpenoid. These skeletons are shown in Figure 15.Mar. Drugs 2018, 16, x FOR PEER REVIEW  12 of 52 
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Compounds considered in this part have been organized according to their sesquiterpenoid
skeletons, and they are subdivided, whenever possible, in an order of increasing substitution and
complexity of the aromatic moiety. We should bear in mind that sometimes more than one type
was found in the same species; thus, the same article may have been referenced more than once.
Those compounds appearing in previous reviews were not considered herein unless some new
bioactivity or synthesis was described.
Thus, the compounds are organized in four subsections: drimane derivatives, aureane derivatives,
avarane derivatives, and other cyclic merosesquiterpenoids. Mainly, the polyketide fractions are
BQ/HQs, but sometimes they can be partially reduced or even etherified, and/or form additional
bonds between both fragments. In this sense, those compounds having relative 1,2- or 1,4-oxigenated
functions at this polyketide core are considered here.
4.3.1. Drimane Skeleton
The meroterpenoids described here were formed by a drimane skeleton attached to a BQ/HQ
system, and they were isolated from sponges, algae, and marine-derived fungi.
Isohyatellaquinone (99) (Figure 16) is a sesquiterpenoid quinone isolated from the sponge
Dactylospongia elegans collected at the Inner Gneering Shoals near Mooloolaba, Australia [49]. It was
isolated along with the known drimane derivatives hyatellaquinone (100) and dictyoceratidaquinone
(101) (Figure 16). The relative stereochemistry of the latter was assigned in that work.
Other sesquiterpenoid quinones, isolated from the same specimen, were mamanuthaquinone and
ilimaquinone, which had a different sesquiterpene skeleton [49].
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Zonarol (102) (Figure 16) is a well-known sesquiterpene HQ that was isolated from the brown 
alga Dictyopteris undulata, and it was described originally as fungitoxic [50], later as 
anti-inflammatory [51] and, more recently, as a protector against dextran sodium sulfate-induced 
colon injury in mice (a model of the inflammatory bowel disease ulcerative colitis) [52]. In addition, 
it was found that zonarol activated the Nrf2/ARE pathway and protected neuronal cells against 
oxidative stress, this being the first time that such activity was reported for any compound from 
brown algae [53]. 
Lane et al. evaluated the antimicrobial defences for 69 collections of Fijian red macroalgae against 
three microbial pathogens of marine macrophytes, and found that some members of the red macroalga 
genus Peyssonnelia showed strong antimicrobial activity [54]. Bioassay-guided chromatography led to 
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Zonarol (102) (Figure 16) is a well-known sesquiterpene HQ that was isolated from the brown alga
Dictyopteris undulata, and it was described originally as fungitoxic [50], later as anti-inflammatory [51]
and, more recently, as a protector against dextran sodium sulfate-induced colon injury in mice (a model
of the inflammatory bowel disease ulcerative colitis) [52]. In addition, it was found that zonarol
activated the Nrf2/ARE pathway and protected neuronal cells against oxidative stress, this being the
first time that such activity was reported for any compound from brown algae [53].
Lane et al. evaluated the antimicrobial defences for 69 collections of Fijian red macroalgae against
three microbial pathogens of marine macrophytes, and found that some members of the red macroalga
genus Peyssonnelia showed strong antimicrobial activity [54]. Bioassay-guided chromatography led
to the isolation of peyssonoic acid A (103) and peyssonoic acid B (104) (Figure 16). They are HQ
meroterpenoids attached to acetic acid; peyssonoic acid A (103) had a brominated drimane decaline,
whereas peyssonoic acid B (104) had a rearranged peyssonane terpenoid. Both inhibited the growth of
two marine alga pathogens, the bacteria Pseudoalteromonas bacteriolytica, and the fungi Lindra thalassiae,
and showed modest antineoplastic activity against ovarian cancer cells [54].
There are several meroterpenoids with a cyclohexenone/cyclohexenedione core attached to the
sesquiterpenoid moiety, and although they are not proper quinones, they are structurally related,
having the same polyketide nature, and as they have oxygen functions in 1,2-/1,4-relative positions,
Mar. Drugs 2018, 16, 292 13 of 52
they have been considered as partially reduced or modified quinones, and so they are included in
this revision.
At the beginning of 2012, Lin et al. published the isolation of a new sesquiterpene quinone,
named penicilliumin A (105) (Figure 17), from a new fungal strain Penicillium sp. F00120, isolated
from a deep-sea sediment sample collected in the northern South China Sea [55]. This compound
inhibited in vitro proliferation of mouse melanoma B16, human melanoma A375 and HeLa cells
moderately. The authors assigned the relative stereochemistry of the drimenyl core, but they did
not determine the absolute configuration at the position C-2′ [55]. A few months later, Fang et al.
isolated a drimenyl cyclohexenone derivative that had the same 1H and 13C data, but that differed
in physical appearance and optical rotation though with the same sign [56]; this came from the
bioactive mutant BD-1-6 of a marine-derived Penicillium purpurogenum G-59. These facts, together
with the predicted and calculated CD spectra, served to assign the structure 105a and claimed it as
a new compound with the name purpurogemutantidin. From the same mutant strain, another new
metabolite, purpurogemutantin (108), and the known macrophorin A (106) were also isolated and
characterized (Figure 17). None of them were produced by the parent strain, but all of them showed
significant antiproliferative effect against several human tumor cell lines [56]. Purpurogemutantin
(108), macrophorin A (106), and 4′-oxomacrophorin A (106a) were also found in the fungus Gliomastix
sp. ZSDS1-F7, isolated from the sponge Phakellia fusca from Yongxing Island of Xisha, along with
several yanuthone A analogues that have been mentioned above (Figure 10). According the authors,
this was the first time that meroterpenoids with both open-chain, and bicyclic drimane skeletons
were reported from the same fungal strain [37]. An example of both types of meroterpenoids in
bacteria is the mutated marine-derived strain of Arctic Streptomyces nitrosporeus YBH10-5, from which
nitrosporeunol G (107), a meroterpenoid related to macrophorin A, was described as a new compound,
along with several farnesylquinones [36].
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From the marine-derived fungus Paraconiothyrium sp. (former Phoma sp.), obtained from the 
marine sponge Ectyplasia perox collected at Caribbean Sea, Dominica, two cyclohexanone derivatives 
epoxyphomalins A (109) and B (110) (Figure 17) were isolated, and they showed highly potent 
cytotoxicity on 12 out of 36 human tumor cell lines. They exerted their effect through inhibition of 
the 20S proteasome, enzymes responsible for the degradation of endogenous proteins [57,58]. 
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From the marine-derived fungus Paraconiothyrium sp. (former Phoma sp.), obtained from the
marine sponge Ectyplasia perox collected at Caribbean Sea, Dominica, two cyclohexanone derivatives
epoxyphomalins A (109) and B (110) (Figure 17) were isolated, and they showed highly potent
cytotoxicity on 12 out of 36 human tumor cell lines. They exerted their effect through inhibition of the
20S proteasome, enzymes responsible for the degradation of endogenous proteins [57,58].
Pleosporallins A–D (111–114) (Figure 17) are meroterpenoids isolated from Pleosporales sp.
a fungus obtained from the marine alga Enteromorpha clathrate, collected at Monkey Island in the
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South China Sea. Pleosporallin D (114) exhibited moderate antibacterial activity and pleosporallins
A-C (111–113), showed anti-inflammatory activity with no detectable cytotoxic effects [59].
In this section, several sesquiterpenequinones/HQs with an additional oxygen bridge between
the decaline and the polyketide ring are considered. This type of additional bond results in the
formation of new fused-pyran or furan rings, which were the objective of many synthetic studies
toward the total synthesis of these interesting bioactive metabolites. Many of them have been
known for a long time, but some new synthetic procedures are being reported. This is the
case for (+)-cyclospongiaquinone-1 (115) and (−)-dehydrocyclospongiaquinone-1 (116), which were
synthesized from (+)-sclareolide by Takeda et al. [60], and several works on puupehenone (117),
related compounds [61,62], or a nature-inspired synthesis of (+)-ent-chromazonarol (119) [63] (Figure 18).
Puupehenol (118) (Figure 18) was described as a new natural compound from a deep-water
Hawaiian sponge Dactylospongia sp. along with the known puupehenone (117), suggesting that the
latter may always be an artefact of the isolation procedures. Both compounds were very effective
antioxidants and antimicrobials towards Gram-positive bacteria [64].
Two new spirane compounds 7,8-dehydrocyclospongiaquinone-2 (122) and 9-epi-7,8-
dehydrocyclospongiaquinone-2 (123) (Figure 18) were isolated, along with other sesquiterpenoid
quinones mentioned above, from the sponge Dactylospongia elegans collected at the Inner Gneering
Shoals near Mooloolaba, Australia [49]. From the same species D. elegans, but collected off the coast of
Palau and obtained from the US NCI’s Open Repository Program, several meroterpenoid quinones
with diverse sesquiterpene skeletons were also isolated. Among those with a drimenyl moiety were
8-epi-ent-chromazonarol (120), cyclospongiaquinone-1 (115), cyclospongiaquinone-2 (121), and the new
HQ cyclospongiacatechol (124) [65] (Figure 18).
Dysidphenols A and B (125 and 126) (Figure 18), are also spiranic meroterpenoids probably
derived from protocatechuic acid. They were isolated from a purple-colored encrusting Dysidea sp.
off the coral-reef near Yongxing Island in the South China Sea, and showed weak antibacterial activity
against E. coli, B. subtilis and S. aureus [66].
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4.3.2. Aureane Skeleton
The meroterpenoids described here are formed by an aureane skeleton attached to a p-BQ or to a
HQ, sometimes forming an additional pyran ring between the two fragments. The aureane skeleton
is less frequent than its analogues, and it could be considered a biogenetically intermediate between
drimane and avarane skeletons through a 1,2-methyl shift.
A sponge of the family Spongiidae, SS-1047, collected off Gesashi, Okinawa (Japan) produced
many aureane and avarane-derived sesquiterpenoidquinones with amine residues on the quinone
ring. Among those having an aureanyl group, were nakijiquinones J, M and P (128–130) (Figure 19).
Nakijiquinone P (130) exhibited a certain inhibitory activity against EGFR (epidermal growth factor
receptor) tyrosine kinase (76% inhibition at 1 mM) [67].
The first iodo-sesquiterpenyl-HQ reported as a natural compound, 6′-iodoaureol (132),
was isolated from the sponge Smenospongia sp. collected at PP Island, Thailand, along with
the new sesqui-THQ dimer 6′-aureoxyaureol (136) [68]. In the same study, other aureanyl-HQs
identified with an ether linkage between both fragments were aureol (131), 6′-chloroaureol (133) and
aureol acetate (134) (Figure 19). The drimane derivative ent-chromazonarol (119) (Figure 18) was
also identified.
D. elegans was collected at the Inner Gneering Shoals near Mooloolaba, Australia, and as
mentioned above, it was also a source of meroterpenoids with an aureane skeleton, such as
mamanuthaquinone (127) (Figure 19) [49]. From a different specimen, Dactylospongia sp., collected at
the same place, and closely related to D. elegans, but likely to be new to science, neomamanuthaquinone
(135) (Figure 19) was isolated as a new natural product, along with ent-isohyetallaquinone (ent-99)
(Figure 16). Neomamanuthaquinone (135) was moderately active against breast cancer (BC), and it
was inactive against small cell lung cancer NCI-H187 cell lines.
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In this type of natural product, it is common to determine the molecular constitution and the 
relative stereochemistry, but the absolute configuration sometimes remains unassigned until the 
total synthesis is performed, either starting from an enantiomerically pure natural compound, or 
using stereocontrolled reactions. This is the case for (+)-strongylin A (137) [69], (+)-aureol (131) [70], 
and (−)-cyclosmenospongine (138) [71], which have been recently reported (Figure 19). 
4.3.3. Avarane Skeleton 
Meroterpenoids with an avarane skeleton (also named 4,9-friedodrimane), are a larger group of 
these marine natural products that have been isolated mainly from sponges. They were found in 
both enantiomeric series, or epimerized at any position with a trans- or cis-fused decaline moiety. It 
is frequent that the same generic name with correlative letters is given for many of them, probably 
Figure 19. Structures of meroterpenoids with an aureane skeleton 127–138.
In this type of natural product, it is common to determine the molecular constitution and
the relative stereochemistry, but the absolute configuration sometimes remains unassigned until
the total synthesis is performed, either starting from an enantiomerically pure natural compound,
or using stereocontrolled reactions. This is the case for (+)-strongylin A (137) [69], (+)-aureol (131) [70],
and (−)-cyclosmenospongine (138) [71], which have been recently reported (Figure 19).
4.3.3. Avarane Skeleton
Meroterpenoids with an avarane skeleton (also named 4,9-friedodrimane), are a larger group
of these marine natural products that have been isolated mainly from sponges. They were found
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in both enantiomeric series, or epimerized at any position with a trans- or cis-fused decaline moiety.
It is frequent that the same generic name with correlative letters is given for many of them, probably
following the isolation order from the extracts, but independently of their structural features. Even,
compounds with different sesquiterpene skeleton received the same generic name, making it difficult
to follow and identify them. In addition, it was found that high variability in the amount of secondary
metabolites in the same sponges, depending on the collecting zone, and even on the specific parts of
their tissues (central part, peripheral zone, etc.), and only a few studies about the influence of those
factors have been published [72,73].
Because more than one type or isomers were isolated from the same species, we presented the
structures of all of them together at the beginning of this subsection, according to the structural
similarities instead the chronological description, although afterwards, the discussion is based mainly
on their source. Thus, the compounds were numbered correlatively in the tables by their structural
similarities, but not by their appearance in the text. The compounds considered are shown in Tables 1–7
and Figure 20, and are classified as quinones and HQs, grouped according the cis- or trans-fusion in
the decaline core and then, differentiating those with an endocyclic bond at C-3 from those with the
exocyclic bond at C-4(14). There are also several compounds with oxygen bridges between both parts
of the meroterpenoid forming additional pyran or oxepane rings, which are shown in Figure 21.
Table 1. Meroterpenoid analogues of avarone with a trans-decaline.
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following the isolation order from the extracts, but independently of their structural features. Even, 
compounds with different sesquiterpene skeleton received the same generic name, making it 
difficult to follow and identify them. In addition, it was found that high variability in the amount of 
secondary metabolites in the same sponges, depending on the collecting zone, and even on the 
specific parts of their tissues (central part, peripheral zone, etc.), and only a few studies about the 
influence of those factors have been published [72,73]. 
Because more than one type or isomers were isolat   the same species, we present d he 
structures of all of them tog ther at the begi ning of thi  section, according to the structural 
similarities instead the chronological description, although afterwards, the discussion is based 
mainly on their source. Thus, the compounds were numbered correlatively in the tables by their 
structural similarities, but not by their appearance in the text. The compounds considered are shown 
in Tables 1–7 and Figure 20, and are classified as quinones and HQs, grouped according the cis- or 
trans-fusion in the decaline core and then, differentiating those with an endocyclic bond at C-3 from 
those with the exocyclic bond at C-4(14). There are also several compounds with oxygen bridges 
between both parts of the meroterpenoid forming additional pyran or oxepane rings, which are 
shown in Figure 21. 
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following the isolation order from the extracts, but independently of their structural features. Even, 
compounds with different sesquiterpene skeleton received the same generic name, making it 
difficult to follow and identify them. In addition, it was found that high variability in the amount of 
secondary metabolites in the same sponges, depending on the collecting zone, and even on the 
specif c parts of their tissues (central part, p ripheral zone, etc.), and only a few studies abo t the 
influence of those factors ave been published [72,73]. 
Because ore than one type or isomers were isolated from the same species, we presented the 
structures of all of them together at the beginning of this subsection, according to the structural 
similarities instead the chronological description, although afterwards, the discussion is based 
mainly on their source. Thus, the compounds were numbered correlatively in the tables by their 
structural similarities, but not by their appearance in the text. The compounds considered are shown 
in Tables 1–7 and Figure 20, and are classified as quinones and HQs, grouped according the cis- or 
trans-fusion in the decaline core and then, differentiating those with an endocyclic bond at C-3 from 
those with the exocyclic bond at C-4(14). There are also several compounds with oxygen bridges 
between th p rts of the meroterp noid forming additi nal pyran or oxepane ring , which are 
shown in Figure 21. 
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following the isolation o der fro  he extracts, but in ependen ly of their structural featur s. Even, 
co pounds with different s squit rpene skeleton receiv d the sa  ge eric na e, aking it 
difficult to follow and identify the . In add ion, it was found that high variability in the a ount of 
secondary e abolites in the sa e sponges, epending on th  collecti g zone, and even on the 
specific parts of their tissues (cent al art, peripheral zone, tc.), and only a few studies about the 
influence of those factors have been published [72,73]. 
B caus ore than one type or iso rs were isolated fro  th a e species, w  presented the 
structures of all of the  together at the beginning of this subsection, according to the structural 
s ilarities instead the chrono ogical description, although afterwards, the d scus ion is based 
ainly on their source. T us, the co pounds were nu bered corr lat vely in th  tables by their 
structural si ilarities, but not by their appearance in the text. The co pounds considered are shown 
in Tables 1–7 and Figure 20, and re classified as quinones and HQs, grouped according the cis- or 
trans-fusion in the d caline core and then, differentiating those with an endocyclic bond at C-3 fro  
those with the exocyclic bond at C-4(14). Th re are also several co pounds with oxygen bridges 
between both par s of the eroterpenoid for ing additional py an or oxepane rings, which are 
shown in Figure 21. 





R1 R2 Na e  R Na e  
H H avarone 139  nakijiquinone S 148 
H NH2 3′-a in avarone 140  nakijiquinone K 149 
H 
 
dysida inone C 141 
 
nakijiquinone N 150 
 H dysida inone D 142  nakijiquinone O 151 
H  dysida inone E 143  
nakijiquinone Q 152 
 
H dysida inone A 144 
 
nakijiquinone G 153 
H 
 
dysida inone B 145 
 
nakijiquinone H 154 
 
H dysida inone F 146 
 
nakijiquinone I 155 
 
H dysida inone G 147 
 
nakijiquinone R 156 
  
ijiquinone N 150
Mar. Drugs 2018, 16, x FOR PEER REVIEW  16 of 52 
 
following the isolation order from th  extracts, but in epen ently of their structural features. Even, 
compounds with different sesquiterpen  skel ton received the same generic name, making it 
difficult to follow and identify them. In addition, it was found th t igh variability in the amount of 
secondary metabolit s i  the s me sponges, de ending on the collecting zone, and even on the 
specific parts of th ir tissues (central part, ripheral zone, etc.), and only a few studies about the 
influence of those factors h ve been published [72,73]. 
Because ore than one type or isomers were isolated fr m the same speci s, we presented the 
structures of all of them toget er at t e beginning of this subsection, a co ding t  the structural 
similarities instead the chronological description, although afterwards, the discussion is bas d 
mainly on their source. Thus, the compounds were numbered correlatively i  the tabl s by their 
structural similarities, but not by t eir appear ce in the text. The compounds considered are shown 
in Tables 1–7 and Figure 20, and are classified as quinones and HQs, grouped accordi g the cis- or 
trans-fusion in the decaline core and t en, differentiating those with an e doc clic bond at C-3 from 
those with the exocyclic bond at C-4(14). There are also several compounds with oxygen bridges 
between both parts of the meroterpenoid forming additional pyran or oxepane rings, which are 
shown in Figure 21. 
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follo ing the isolation order from the extracts, but independently of their structural features. Even, 
compounds ith different sesquiterpene skeleton received the same generic name, making it 
difficult to follo  and ide tify them. In additi n, it as found that high variability in the amount of 
secondary met bolites i  the sam  sponges, depending on the collecting zone, and even on the 
specific parts of their tissues (central part, peripheral zone, tc.), and only a fe  studies about the 
influence of those factors have been published [72,73]. 
Because more than one type or isomers ere isolated from the same species, e presented the 
structures of all of them together at the beginning of this subsection, according to the structural 
similarities instead the chronological description, although after ards, the discussion is based 
mainly on their source. Thus, the compounds ere numbered correlatively in the tables by their 
structural similarities, but not by their appearance in the text. The compounds considered are sho n 
in Tables 1–7 and Figure 20, and are classified as quinones and s, grouped according the cis- or 
trans-fusion in th  decaline core and then, differentiating thos  ith an endocyclic bond at -3 from 
those ith the exocyclic bond a  -4(14). Th re are also several compounds ith xygen bridges 
bet een both parts of the meroterpenoid forming additional pyran or oxepane rings, hich are 
sho n in Figure 21. 
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following the isolation order from the extract , b t i dependently of their s ructural f atures. Even, 
compounds with different sesquiterpene skeleton received the same generic nam , maki g it 
difficult to follow and identify them. In addition, it w s found that high variability in the amount of 
secondary metabolites in the ame sponges, dependi g n t e collecting zone, and ven on the 
specific parts of their tissues (central part, perip e l zone, etc.), nd o ly a few studies about the 
influence of those factors have been published [72,73]. 
Because more than one type or isomers were isolated from the a  pecies, w  presented the 
structures of all of them together at the begin ing f this subsec ion, according t  th  str ctural 
similarities instead the chronological description, although afterwards, the discussi n is based 
mainly on their source. Thus, the compounds were numbered correlatively i  the tables by thei  
structural similarities, but not by their appear ce in the tex . The compou ds considered ar  shown 
in Tables 1–7 and Figure 20, and are classified as quinon s HQs, grouped accordi g the cis- or 
trans-fusion in the decaline core d then, differ ntiating th s with an end cyclic bo d at C-3 from 
those with the exocyclic bond at C-4(14). T ere are also several compounds with oxygen b idges 
between both parts of the mero erp oid forming additional pyran r oxepa e rings, which are 
shown in Figure 21. 





R1 R2 Name  R Name  
H H avarone 139  kijiquinone S 148 
H NH2 3′-aminoavarone 140  nakijiqu  K 149 
H 
 
dysidaminone C 141 
 
nakijiqui  N 150 
 H dysidaminone D 142  nakijiquinone O 151 
H  dysidaminone E 143  
nakijiquinone Q 152 
 
H dysidaminone A 144 
 
nakijiquinone G 153 
H 
 
dysidaminone B 145 
 
nakijiquinone H 154 
 
H dysidaminone F 146 
 
nakijiquinone I 155 
 
H dysidaminone G 147
 
nakijiquinone R 156 
  
dysidaminone E 143
Mar. Drugs 2018, 16, x FOR PEER REVIEW  16 of 52 
 
following the isolation order fro  the extracts, but independently of their structural features. Even, 
c pounds with different sesquiterpene skeleton received the sa e generic na e, aking it 
difficult to follow and ide tify the . In additi n, it was foun  t at high variability in the a ount of 
secondary etabolites in the sa e sponges, depending o  the collecting zone, a d even on the 
specific parts of their tissues (central art, eripheral zone, etc.), and only a few stu ies about t e 
influence of th se factors have been published [72,73]. 
Because ore than one ty e or iso ers were isolated fro  the sa e species, we presented the 
structures of all of the  together at the beginning of this subsection, according to the structural 
si ilarities instead the chronological descriptio , although afterwards, the discussion is based 
ainly on their source. T us, the co pounds were nu bered correlatively in the tables by th ir 
structural si ilarities, but not by their a pearance in the text. The co pounds considered are shown 
in Tables 1–7 and Figure 20, nd are classifi d as quin nes and HQs, group  ccording the cis- or 
trans-fusion in th  decaline core and the , differentiatin  those with an endocycli  bond at C-3 fro  
those with the exocyclic bon  at C-4(14). There are also several co pounds with xygen bridges 
between bot  parts of the eroterpenoid for ing additional pyran or oxepane rings, which are 
sho n in Figure 21. 
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following the isolation order from the extracts, but independ tly of th ir structur l featur s. Even, 
compounds with different sesquiterpene skeleton received the ame g neric n me, making it 
difficult to follow and identify them. In addition, it was found that high variability in the amount of 
secondary metabolites in the same sponges, depending on the collecting zone, and eve  on the 
specific parts of their tissues (central part, peripheral zone, etc.), and only a f w st dies ab ut the 
influence of those factors have been published [72,73]. 
Because more than one type or isomers were isolated from the same species, we presented the 
structures of all of them together at the beginning of this sub ection, according to th  structural 
similarities instead the chronological description, although afterwards, th  discussion is based 
mainly on their source. Thus, the compounds were numbered correlatively in the tables by their 
structural similarities, but not by their appearance in the text. T  c mpou ds considered are sh wn 
in Tables 1–7 and Figure 20, and are classified as quinones and HQs, grouped according the cis- or 
trans-fusion in the decaline core and then, differentiating those with an endocyclic bond at C-3 f om 
those with the exocyclic bond at C-4(14). There are also several compounds with oxygen bridges 
between both parts of the meroterpenoid forming additional pyran or oxepane rings, which are 
shown in Figure 21. 
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following the isolation order from the extracts, but inde en ently of their structural features. Even, 
c mpounds with different sesquiterpene skeleton received the same generic name, making it 
difficult to follow and ide tify them. In addition, it was foun  t at high variability in the amount of 
secondary me ab li s in the same s o g s, d pend ng o  the collecting zone, a d even on the 
specifi  part  of heir tissues (ce tral art, peripheral zone, etc.), and only a few stu ies about t e 
i fluence of t se factors h ve bee  published [72,73]. 
Because more tha  one typ  or isomers were isolated from the same species, we presented the 
structures of all of them tog ther at th  eginning of this sub ection, according to the structural 
similarities instead the chronological d script o , although aft rwards, the iscussion is based 
mai ly on their source. T us, the compounds w re numbered correlatively in the tables by their 
structural similari es, but not by their a pearan e i  the text. The compounds considered are shown 
i  Tables 1–7 nd Figure 20, and are class fied as quinones and HQs, grouped according the cis- or 
trans-fusion in the d caline core and then, differ ntiating those with an endocyclic bond at C-3 from 
those with the ex cyclic bond at C-4(14). re are also everal compounds ith xygen bridges 
between bot  part  of th  merote penoid forming addition l pyran or oxepane rings, which are 
sho  in Figure 21. 
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following the isolation order from the extracts, but ind pendently f their structural features. Ev n, 
compounds with different sesquiterpene skeleto  r ceived the same g neric name, aking it 
difficult to follow and identify them. In additi n, it was found that high variability in the amount of 
secondary metabolites in the same sponges, depending on the collecting zone, and even on the 
specific parts of their tissues (central part, peripheral zone, etc.), and only a f w studies about the
influence of those factors have been published [72,73]. 
Because more than one type or isomers were isolated from the same species, we presented the 
structures of all of them together at the beginning of this subsection, according to the structural 
similarities instead the chronological description, although afterwards, the discussion is based 
mainly on their source. Thus, the compounds were numbered correlatively in the tables by their 
structural similarities, but not by their appearance in the text. The compounds considered are shown 
in Tables 1–7 and Figure 20, and are classified as quinones and HQs, grouped according the cis- or 
trans-fusion in the decaline core and then, differentiating those with an endocyclic b d at C-3 from 
those with the exocyclic bond at C-4(14). There are also several compounds with xygen bridges 
between both parts of the meroterpenoid forming additional pyran or oxepane rings, which are 
shown in Figure 21. 
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follo ing the isolation order fro  the extracts, but independently of their structural features. Even, 
c pounds ith different sesqui erpene skeleton received the sa  generic na e, aking it 
difficult to follo  and id ify the . In addition, it as foun  t at high variability in the a ount of 
secondary etabolites in the sa e sponges, depending o  the collecting zone, a d ven on the 
pecific parts of their tissues (central art, eriph ral zone, e c.), a d only a fe  stu i s about  
influence of th se factors have been published [72,73]. 
Be ause ore t an one ty  or iso ers ere isolated fro  the sa e species, e presented the 
s ructures f all of the  tog th r at the beginning of this subsection, according to th  structural 
i ilarities instead the chron logical descriptio , although after ards, the iscussion is based 
ainly on their sourc . T us, the co ounds ere nu bered correlatively in the tables by th ir 
structural si ilaritie , but not by heir a pearance in the text. The co pounds considered are sho n 
in Tables 1–7 and Figure 20, and are classified as quinon s and s, groupe  according the cis- or 
trans-fusion in the decali e core and then, differentiating those ith an endocyclic bond at C-3 fro  
hose ith the exocy lic bo  at C-4(14). Th r  are also sev ral co pounds with xygen bridges 
bet een bot  parts of the eroterpenoid for ing additional pyra  or oxepane ri gs, hich are 
sho n in Figure 21. 
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following the isolation order from the extracts, but indep ndently of th ir stru tural featur s. Even, 
compounds with different sesquiterpene sk leto  received the same gen ric name, king it 
difficult to follo  and identify them. In additi n, it was found that high variability in the am unt of 
secondary metabolites in the same sponges, depending on the collecting zone, and even on the 
specific parts of their tissues (central part, peripheral zone, etc.), and only a few studies about the 
influence of those factors have been published [72,73]. 
Because more than one type or isomers were isolated from the same species, we presented the 
structures of all of them together at the beginning of this subsection, according to the structural 
similarities instead the chronological description, although afterwards, the discussion is b sed 
mainly on their source. Thus, the compounds were numbered correlatively in the tables by their 
structural similarities, but not by their appearance in the text. The compounds considered are shown 
in Tables 1–7 and Figure 20, and are classified as quinones and HQs, grouped according the cis- or 
trans-fusion in the decaline core and then, differentiating those with an endocyclic bond at C-3 from 
those with the exocyclic bond at C-4(14). There are also several compounds with oxygen bridges 
between both parts of the meroterpenoid forming additional pyran or oxepane rings, which are 
shown in Figure 21. 
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following the isolation order from the extracts, but independently of their structural features. Even, 
c mpounds with different sesqui erp ne skeleton received the sam  generic name, making it 
difficult to follow and id ify them. In addition, it was foun  that high variability in the amou t of 
secondary metabolites in the same sponges, depending o  the collecting zone, a d even on he 
pecific p rts of their tissu  (central art, ripheral zon , e c.), a d only a few stu i s about  
nfl nce of h se factor  have been published [72,73]. 
Be ause more t n one ty  or isomers were isolated from the same species, we presented the 
structures of all of the  togeth r at the b ginning of this subsection, according to th  structural 
imilarities instead the chronological descriptio , although aft rwards, the discussion is based 
mainly on their source. T us, the compounds were numb ed correlatively in the tables by th ir 
structural similarities, but not by their a pearance in the text. The compounds considered ar  shown 
in Tables 1–7 and Figure 20, and ar  classified as quinon s and HQs, groupe  according the cis- or 
trans-fusion in the decali e core and th n, differentiating those with an endocyclic bond at C-3 from 
hose with the exocy lic bo  at C-4(14). There are al o sev ral compounds with xygen bridges 
betwe n bo  parts f the m ro erpenoid formi g dditional pyra  or oxepane i gs, which are 
sho n in Figure 2 . 
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following the isolation order from the extracts, but independently of their stru tural features. Ev n, 
compounds with different esquiterpene skeleton rec ived th  sa  ge eric n m , maki g it 
difficult to follow and identify them. I  addition, it was found that hig  variabilit  in the amount of 
secondary metabolites in the same sponges, d p nding on the c llecti g zone, and even n the 
specific parts of their tissues (central part, peripheral zon , etc.), a d only a few stu ies ab ut the 
influence of t  factors have been published [72,73]. 
Because more than one type or iso ers wer  isolated from the sa  sp cies, we pr s nted the 
structures of all of them together at the beginning of this subsection, according to the structural 
similarities instead the chronological description, although afterwards, the discussion is based 
mainly on their source. Thus, the compounds were numbered correlatively in the tables by their 
structural similarities, but not by their appearance in the text. The compounds considered are shown 
in Tables 1–7 and Figure 20, and are classified as quinones and HQs, grouped according the cis- or 
trans-fusion in the decaline core and then, differentiating those with an endocyclic bond at C-3 from 
those with the exocyclic bond at C-4(14). There are also several compounds with oxygen bridg s 
between both parts of the meroterpenoid forming additional pyran or oxepane rings, which are 
shown in Figure 21. 
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Table 2. Meroterpenoid analogues of neoavarone with a trans- or cis-decaline.
Mar. Drugs 2018, 16, x FOR PEER REVIEW  17 of 52 
 





R1 R2 Name  R1 R2 Name  
H H neoavarone 157 H H arenarone 166 
H OEt 18-ethoxyneoavarone 158 H NH2 18-aminoarenarone 167 
OEt H 19-ethoxyneoavarone 159 NH2 H 19-aminoarenarone 168 
H  dysidaminone H 160 H  18-methylaminoarenarone 169 
 H dysidaminone I 161  H 19-methylaminoarenarone 170 
H  dysidaminone J 162 H  melemeleone C 171 
 H dysidaminone K 163 H  
melemeleone D 172 
 H dysidaminone L 164     
 
H dysidaminone M 165     
Table 3. Meroterpenoid analogues of neoavarone with a trans-decaline. 
 
R Name  R Name  





OCH3 ilimaquinone 174 
 
nakijiquinone L 181 
 langcoquinone C 175  
langcoquinone F 182 







(langcoquinone A) 177  
smenospongine C 184 
 smenospongorine 178  
langcoquinone B 185 
Mar. Drugs 2018, 16, x FOR PEER REVIEW  17 of 52 
 





R1 R2 Name  R1 R2 Name  
H H neoavarone 157 H H arenarone 166 
H OEt 18-ethoxyneoavarone 158 H NH2 18-aminoarenarone 167 
OEt H 19-ethoxyneoavarone 159 NH2 H 19-aminoarenarone 168 
H  dysidaminone H 160 H  18-m thylaminoarenarone 169 
 H dysidaminone I 161  H 19-m thylaminoarenarone 170 
H  dysidaminone J 162 H  melemeleone C 171 
 H dysidaminone K 163 H  
melemeleone D 172 
 H dysidaminone L 164     
 
H dysidaminone M 165     
Table 3. Meroterpenoid analogues of neoav rone with a trans-decaline. 
 
R Name  R Name  





OCH3 ilimaquinone 174 
 
nakijiquinone L 181 
 langcoquinone C 175  
langcoquinone F 182 







(langcoquinone A) 177  
smenospongine C 184 
 sm nospongorine 178  
langcoquinone B 185 
R1 2 Name R1 R2 Name
H H neoavarone 157 H H arenarone 166
H OEt 18-ethoxyneoavarone 158 H NH2 18-aminoarenarone 167
OEt H 19-ethoxyneoavarone 159 NH2 H 19-aminoarenarone 168
H
Mar. Drugs 2018, 16, x FOR PEER REVIEW  17 of 52 
 





R1 R2 Name  R1 R2 Name  
H  neoavarone 157 H H arenarone 166 
H  18-ethoxyneoavarone 158 H NH2 18-aminoarenarone 167 
OEt  19-ethoxyneoavarone 159 NH2 H 19-aminoarenarone 168 
H  dysidaminone H 160 H  18-methylaminoarenarone 169 
 H dysidaminone I 161  H 19-methylaminoarenarone 170 
H  dysidaminone J 162 H  melemeleone C 171 
 H dysidaminone K 163 H  
melemeleone D 172 
 H dysidaminone L 164     
 
H dysidaminone M 165     
Table 3. Meroterpenoid analogues of neoavarone with a trans-decaline. 
 
R Name  R Name  





OCH3 ilimaquinone 174 
 
nakijiquinone L 181 
 langcoquinone C 175  
langcoquinone F 182 







(langcoquinone A) 177  
smenospongine C 184 
 smenospongorine 178  
langcoquinone B 185 
ysidaminone H 160 H
Mar. Drugs 2018, 16, x FOR PEER REVIEW  17 of 52 
 





R1 R2 Name  R1 R2 Name  
H  neoavarone 157 H H arenarone 166 
H OEt 18-eth xyneoav one 158 H NH2 18-aminoarenarone 167 
OEt  19-eth xyneoav one 159 NH2 H 19-aminoarenarone 168 
H  dysidaminone H 160 H  18-methylaminoarenarone 169 
 H dysidaminone I 161  H 19-methylaminoarenarone 170 
H  dysidaminone J 162 H  melemeleone C 171 
 H dysidaminone K 163 H  
melemeleone D 172 
 H dysidaminone L 164     
 
H dysidaminone M 165     
Table 3. Meroterpenoid analogues of neoavarone with a trans-decaline. 
 
R Name  R Name  





OCH3 ilimaquinone 174 
 
nakijiquinone L 181 
 langcoquinone C 175  
langcoquinone F 182 







(langcoquinone A) 177  
smenospongine C 184 
 sme ospongorine 178  
langcoquinone B 185 
18-methylaminoarenarone 169
Mar. Drugs 2018, 16, x FOR PEER REVIEW  17 of 52 
 





R1 R2 Name  R1 R2 Name  
H H neoavarone 157 H H arenarone 166 
H OEt 18-ethoxyneoavarone 158 H NH2 18-aminoarenarone 167 
OEt H 19-ethoxyneoavarone 159 NH2 H 19-aminoarenarone 168 
H  dysidaminone H 160 H  18-methylaminoar narone 69 
 H dysidaminone I 161  H 19-methylaminoarenarone 170 
H  dysidaminone J 162 H  melemeleone C 171 
 H dysidaminone K 163 H  
melemeleone D 172 
 H dysidaminone L 164     
 
H dysidaminone M 165     
Table 3. Meroterpenoid analogues of neoavarone with a trans-decaline. 
 
R Name  R Name  





OCH3 ilimaquinone 174 
 
nakijiquinone L 181 
 langcoquinone C 175  
langcoquinone F 182 







(langcoquinone A) 177  
smenospongine C 184 
 smenospongorine 178  
langcoquinone B 185 
H dysidaminone I 161
Mar. Drugs 2018, 16, x FOR PEER REVIEW  17 of 52 
 





R1 R2 Name  R1 R2 Name  
H H neoavarone 157 H H arenarone 166 
H OEt 18-ethoxyneoavarone 158 H NH2 18-aminoarenarone 167 
OEt H 19-ethoxyneoavarone 159 NH2 H 19-aminoarenarone 168 
H  dysidaminone H 160 H  18-methylaminoarenarone 169 
 H dysida inone I 161  H 19-methylaminoarenarone 170 
H  dysidaminone J 162 H  melemeleone C 171 
 H dysidaminone K 163 H  
melemeleone D 172 
 H dysidaminone L 164     
 
H dysidaminone M 165     
Table 3. Meroterpenoid analogues of neoavarone with a trans-decaline. 
 
R Name  R Name  





OCH3 ilimaquinone 174 
 
nakijiquinone L 181 
 langcoquinone C 175  
langcoquinone F 182 







(langcoquinone A) 177  
smenospongine C 184 
 smenospongorine 178  
langcoquinone B 185 
H 19-methylaminoarenarone 170
Mar. Drugs 2018, 16, x FOR PEER REVIEW  16 of 52 
 
following the isolation order from the extracts, but independently of their structural features. Even, 
compounds with different sesquiterpene skeleton received the same generic name, making it 
difficult to follow and identify them. In addition, it was found that high variability in the amount of 
secondary metabolites in the same sponges, depending on the collecting zone, and even on the 
specific parts of their tissues (central part, peripheral zone, etc.), and only a few studies about the 
influence of those factors have been published [72,73]. 
Because more than one type or isomers were isolated from the same species, we presented the 
structures of all of them together at the beginning of this subsection, according to the structural 
similarities instead the chronological description, although afterwards, the discussion is based 
mainly on their source. Thus, the compounds were numbered correlatively in the tables by their 
structural similarities, but not by their appearance in the text. The compounds considered are shown 
in Tables 1–7 and Figure 20, and are classified as quinones and HQs, grouped according the cis- or 
trans-fusion in the decaline core and then, differentiating those with an endocyclic bond at C-3 from 
those with the exocyclic bond at C-4(14). There are also several compounds with oxygen bridges 
between both parts of the meroterpenoid forming additional pyran or oxepane rings, which are 
shown in Figure 21. 
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shown in Figure 21. 
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following the isolation order from the extracts, but independently of their structural features. Even, 
compounds with different sesquiterpene skeleton received the same generic name, making it 
difficult to follow and identify them. In addition, it was found that high variability in the amou t of 
secondary metabolites in the same sponges, depending on the collecting zone, and even on the 
specific parts of their tissues (central part, peripheral zone, etc.), and only a few studies about the 
influence of those factors have been published [72,73]. 
Because more than one type or isomers were isolated from the sa e species, we presented the 
structures of all of them together at the beginning of this subsecti n, according t  the structural 
similarities instead the chronological description, although afterwards, the discussion is based 
mainly on their source. Thus, the compounds were numbered c rrelatively in the tables by their 
structural similarities, but not by their appearance in the text. The compounds considered are shown 
in Tables 1–7 and Figure 20, and are classified as quinones and HQs, grouped according the cis- or 
trans-fusion in the decaline core and then, differentiating those with an endocyclic bond at C-3 from 
those with the exocyclic bond at C-4(14). There are also several compounds with xygen bridges 
between both parts of the meroterpenoid forming additional pyran or oxepane rings, which are 
shown in Figure 21. 
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following the isolation order from the extracts, but independently of their structural features. Even, 
compounds with different sesquiterpene skeleton received the same generic name, making it 
difficult to follow and identify them. In addition, it was found that high variability in the amount of 
secondary metabolites in the same sponges, depending on the collecting zone, and even on the 
specific parts of their tissues (central part, peripheral zone, etc.), and only a few studies about the 
influence of those factors have been published [72,73]. 
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structural similarities, but not by their appearance in the text. The compounds considered are shown 
in Tables 1–7 and Figure 20, and are classified as quinones and HQs, grouped according the cis- or 
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between both parts of the meroterpenoid forming additional pyran or oxepane rings, which are 
shown in Figure 21. 
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following the isolation order from the extracts, but independently f their structural features. Even, 
compounds with different sesquiterpene skeleton received the same generic na e, ak g it 
difficult to follow and identify them. In addition, it was found that high variability in the amount of 
secondary metabolites in the same spo ges, depending on the co ecting zone, and ev n  the 
specific parts of their tissues (central part, peripheral zone, etc.), and only a few studies about the 
influence of those factors have been published [7 ,73]. 
Because more than one type or isomers were isolated f om the sam  species, we pr sented the 
structures of all of them together at the b ginning of this subsection, according to the structural 
similarities instead the chronological description, although afterwards, the discu sion is based 
mainly on their source. Thus, the compounds were numbered corr lative y i  the tables by their 
structural similarities, but not by their appearance in the text. The compounds consider d are shown 
in Tables 1–7 and Figure 20, and are classified as quinones a d HQs, grouped according the cis- or 
trans-fusion in the decaline core and then, differentiating those with an endocyclic b nd at C-3 from 
those with the exocyclic bond at C-4(14). There are also several compounds with xyg  bridges 
between both parts of the meroterpe id forming additional pyran or oxepane rings, which are 
shown in Figure 21. 
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those with the exocyclic bond at C-4(14). There are also several compounds with oxygen bridges 
between both parts of the meroterpenoid forming additional pyran or oxepane rings, which are 
shown in Figure 21. 
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following the isolation order from the extracts, but independently of their structur l features. Even, 
compounds with different sesquiterpene skeleton received the same generic name, making it 
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following the isolation order from the extracts, but independently of their structural features. Even, 
compounds with different sesquiterpene skeleton received the same generic name, making it 
difficult to follow and identify them. In addition, it was found that high variability in the amount of 
secondary metabolites in the same sponges, depending on the collecting zone, and even on the 
specific parts of their tissues (central part, peripheral zone, etc.), and only a few studies about the 
influence of those factors have been published [72,73]. 
Because more than one type or isomers were isolated from the same species, we presented the 
structures of all of them together at the beginning of this subsection, according to the structural 
similarities instead the chronological description, although afterwards, the discussion is based 
mainly on their source. Thus, the compounds were numbered correlatively in the tables by their 
structural similarities, but not by their appearance in the text. The compounds considered are shown 
in Tables 1–7 and Figure 20, and are classified as quinones and HQs, grouped according the cis- or 
trans-fusion in the decaline core and then, differentiating those with an endocyclic bond at C-3 from 
those with the exocyclic bond at C-4(14). There are also several compounds with oxygen bridges 
between both parts of the meroterpenoid forming additional pyran or o epane rings, which are 
shown in Figure 21. 





R1 R2 Name  R Name  
H H avarone 139  nakijiquinone S 148 
H NH2 3′-aminoavarone 140  nakijiquinone K 149 
H 
 
dysidaminone C 141 
 
nakijiquino e N 150 
 H dysidaminone D 142  nakijiquinone O 151 
H  dysidaminone E 143  
nakijiquinone Q 152 
 
H dysidaminone A 144 
 
nakijiquinone G 153 
H 
 
dysidaminone B 145 
 
nakijiquinone H 154 
 
H dysidaminone F 146 
 
nakijiquinone I 155 
 
H dysidaminone G 147 
 
nakijiquinone R 156 
  
5-epi- iji inone N 188 t 5-epi-20- - t lsmenoquinone 193
Mar. Drugs 2018, 16, x FOR PEER REVIEW  16 of 52 
 
following the isolation order from the extracts, but independently of their structural features. Even, 
compo nds with different sesquiterpene skeleton received the same generic name, making it 
difficult to follow and identify them. In addition, it was found that high variability in the amount of 
secondary metabolites in the same sponges, depending on the collecting zone, and even on the 
specific parts of their tissues (central part, peripheral zone, etc.), and only a few studies about the 
influence of those factors have been published [72,73]. 
Because more than one type or isomers were isolated from the same species, we presented the 
structures of all of them together at the beginning of this subsection, according to the structural 
similarities instead the chronological description, although afterwards, the discussion is based 
mainly on their source. Thus, the compounds were numbered correlatively in the tables by their 
structural similarities, but not by their appearance in the text. The compounds considered are shown 
in Tables 1–7 and Figure 20, and are classified as quinones and HQs, grouped according the cis- or 
trans-fusion in the decaline core and then, differentiating those with an endocyclic bond at C-3 from 
those with the exocyclic bond at C-4(14). There are also several compounds with oxygen bridges 
between both parts of the meroterpenoid forming additional pyran or oxepane rings, which are 
shown in Figure 21. 





R1 R2 Name  R Nam   
H H avarone 139  nakijiquinone S 148 
H NH2 3′-aminoavarone 140  nakijiquinone K 149 
 
 
dysidaminone C 141 
 
nakijiquinone N 150 
 H dysida inone D 142  nakijiquinone O 151 
H  E 3  
iji i  Q 2 
 
H dysidaminone A 144 
 
nakijiquinone G 153 
H 
 
dysida inone B 145 nakijiquinone H 154 
 
H dysida inone F 146 
 
nakijiquino e I 155 
 
H dysidaminone G 147 
 
nakijiquinone R 156 
  
5-epi-nakijiquinone Q 189 NH2 5-epi-smenospongine 194





langcoquinone D 186 
    langcoquinone E 187 
Table 4. M rot rpenoid analo es of avarone or neoavarone with a cis-decaline. 
  
R Name  R Name  
 
5-epi-nakijiquinone N 188 OEt 5-epi-20-O-ethylsmenoquinone 193 
 
5-epi-nakijiqui   189 NH2 5-epi-smenospongine 194 
 
5-epi-nakijiquinone S 190  N-methyl-5-epi-smenospongine 195 
 
5-epi-nakijiquinone U 191    
 
5-epi-nakijiquinone T 192    
Table 5. Meroterpenoids with a HQ fragment. 
  
R1 R2 R3 Name  R1 R2 R3 Name  
H H H avarol 196 H H H neoavarol 197 
Ac H H 17-O-acetylavarol 198 Ac H H 17-O-acetylneoavarol 199 
H H 
 
dysivillosin A 200 H H 
 
dysivillosin B 201 
H 
 
H dysivillosin C 202 H 
 
H dysivillosin D 203 
  
5-epi-nakijiqui 190
Mar. Drugs 2018, 16, x FOR PEER REVIEW  17 of 52 
 





R1 R2 Name  R1 R2 Name  
H H neoavarone 157 H H arenarone 166 
H OEt 18-ethoxyneoavar ne 158 H NH2 18-aminoarenarone 167 
OEt H 19-ethoxyneoavarone 159 NH2 H 19-aminoarenarone 168 
H  dysidaminone H 160 H  18-methylaminoarenarone 169 
 H dysidaminone I 161  H 19-methylaminoarenarone 170 
H  dysidaminone J 162 H  melemeleone C 171 
 H dysidaminone K 163 H  
melemeleone D 172 
 H dysidaminone L 164     
 
H dysidaminone M 165     
Table 3. Meroterpenoid analogues of neoavarone with a trans-decaline. 
 
R Name  R Name  





OCH3 ilimaquinone 174 
 
nakijiquinone L 181 
 langcoquinone C 175  
langcoquinone F 182 







(langcoquinone A) 177  
smenospongine C 184 
 smenospongorine 178  
langcoquinone B 185 
N-methyl-5-epi-smenospongine 195
Mar. Drugs 2018, 16, x FOR PEER REVIEW  17 of 52 
 





R1 R2 Name  R1 R2 Name  
H H neoavarone 157 H H arenarone 166 
H OEt 18-ethoxyneoavarone 158 H NH2 18-aminoarenarone 167 
OEt H 19-ethoxyneoav rone 159 NH2 H 19-amino renarone 168 
H  dysidaminone H 160 H  18-methylaminoarenarone 169 
 H dysidaminone I 161  H 19-methylaminoarenarone 170 
H  dysidaminone J 162 H  melemeleone C 171 
 H dysidaminone K 163 H  
melemeleone D 172 
 H dysidaminone L 164     
 
H dysidaminone M 165     
Table 3. Meroterpenoid analogues of neoavarone with a trans-decaline. 
 
R Name  R Name  





OCH3 ilimaquinone 174 
 
nakijiquinone L 181 
 langcoquinone C 175  
langcoquinone F 182 







(langcoquinone A) 177  
smenospongi  C 184 
 smenospongorine 178  
langco i e B 185 5-epi-nakijiquinon 191
Mar. Drugs 2018, 16, x FOR PEER REVIEW  18 of 52 
 
 
sme ospongiarine 179 
 
langcoquinone D 186 
    langcoquinone E 187 
Table 4. Meroterpenoid analogues of avarone or neoavarone with a cis-decaline. 
  
R Name  R Name  
 
5-epi-nakijiquinone N 188 OEt 5-epi-20-O-ethylsmenoquinone 193 
 
5-epi-nakijiquinone Q 189 NH2 5-epi-smenospongine 194 
 
5-epi-nakijiquinone S 190  N-methyl-5-epi-smenospongine 195 
 
5-epi-nakijiquinone U 191    
 
5-epi-nakijiquinone T 192    
Table 5. Meroterpenoids with a HQ fragment. 
  
R1 R2 R3 Name  R1 R2 R3 Name  
H H H avarol 196 H H H neoavarol 197 
Ac H H 17-O-acetylavarol 198 Ac H H 17-O-acetylneoavarol 199 
H H 
 
dysivillosin A 200 H H 
 
dysivillosin B 201 
H 
 
H dysivillosin C 202 H 
 
H dysivillosin D 203 
  
5-epi-nakijiqui 192
Table 5. Me rpenoids with a HQ fragment.
ar. rugs 2018, 16, x F   I   18 of 52 
 
 
s s i ri   
 
l c i    
    l c i    
a le 4. er ter i  a al es f a ar e r e a ar e it  a cis- ecali e. 
  
      
 
-e i- iji i    t -e i- - - t ls i   
 
-e i- iji i    2 -e i-s s i   
 
-e i- iji i     - t l- -e i-s s i   
 
-e i- iji i       
 
-e i- iji i       
a le 5. er ter i s it  a  fra e t. 
  
1 2 3   1 2 3   
   r l     r l  
c   - - c t l r l  c   - - c t l r l  
  
 
si ill si      
 
si ill si    
 
 
 si ill si     
 
 si ill si    
  
Mar. Drugs 2018, 16, x FOR P ER REVIEW  18 of 52 
 
 
smen spongiarine 179 
 
langcoquinone D 186 
    langcoquinone E 187 
Table 4. Meroterpenoid analogues of avarone or neoavarone with a cis-decaline. 
  
R Name  R Name  
 
5-epi-nakijiquinone N 1 8 OEt 5-epi-20-O-ethylsmenoquinone 193 
 
5-epi-nakijiquinone Q 189 NH2 5-epi-smen spongine 194 
 
5-epi-nakijiquinone S 190  N-methyl-5-epi-smen spo gine 195 
 
5-epi-nakijiquinone U 191    
 
5-epi-nakijiquinone T 192    
Table 5. Meroterpenoids with a HQ fragment. 
  
R1 R2 R3 Name  R1 R2 R3 Name  
H H H avarol 196 H H H neoavarol 197 
Ac H H 17-O-acetylavarol 198 Ac H H 17-O-acetylneoavarol 1 9 
H H 
 
dysiv llosin A 2 0 H H 
 
dysiv llosin B 201 
H 
 
H dysiv llosin C 202 H 
 
H dysiv llosin D 203 
  
R1 R2 3 e 1 2 3 Name
H H H avarol 196 H H neo l 197
Ac H H 17-O-acetylavarol 198 Ac H H 17-O-acetylneoavarol 199
H H





langcoquinone D 186 
    langcoquinone E 187 
Table 4. Meroterpenoid analogues of avarone or neoavarone with a cis-decaline. 
  
R Name  R Name  
 
5-epi-nakij quinone N 188 OEt 5-epi-20-O-ethylsmenoquinone 193 
 
5-epi-nakijiquinone Q 189 NH2 5-epi-smenospongine 194 
 
5-epi-nakijiquinone S 190  N-methyl-5-epi-smenospongine 195 
 
5-epi-nakijiquinone U 191    
 
5-epi-nakijiquinone T 192    
Table 5. Meroterpenoids with a HQ fragment. 
  
R1 R2 R3 Name  R1 R2 R3 Name  
H H  av rol 1    H neoav rol 197 
Ac H  17-O-acetylavar  1    H 17-O-acetylneoavarol 199 
H H 
 
dysivillosin A 200 H H 
 
dysivillosin B 201 
H 
 
H dysivillosin C 202 H 
 
H dysivillosin D 203 
  
dysivillosin 2
Mar. Drugs 2018, 16, x FOR PEER REVIEW  18 of 52 
 
 
sme ospongiarine 179 
 
langcoquinone D 186 
    langcoquinone E 187 
Table 4. Meroterpenoid analogues of avarone or neoavarone with a cis-decaline. 
  
R Name  R Name  
 
5-epi-nakijiquinone N 188 OEt 5-epi-20-O-ethylsmenoquinone 193 
 
5-epi-nakijiquino  Q 189 NH2 5-epi-smenospongine 194 
 
5-epi-nakijiquinone S 190  N-methyl-5-epi-smenospongine 195 
 
5-epi-nakijiquinone U 191    
 
5-epi-nakijiquinone T 192    
Table 5. Meroterpenoids with a HQ fragment. 
  
R1 R2 R3   R1 R2 R3 Name  
H H H avarol 1 6 H H H neoavarol 197 
Ac H  17-O-acetylav rol 198 Ac H H 17-O-acetylneoavarol 199 
H H 
 
si ill si  A 200 H H 
 
dysivillosin B 201 
H 
 
H C 20  H 
 









langcoquinone D 186 
    langcoquinone E 187 
Table 4. Meroterpenoid analogues of avarone or neoavarone with a cis-decaline. 
  
R Name  R Name  
 
5-epi-nakijiquinone N 188 OEt 5-epi-20-O-ethylsmenoquinone 193 
 
5-epi-nakijiqui one Q 189 NH2 5-epi-s nospong ne 194 
 
5-epi-nakijiquinone S 190  N-methyl-5-epi-smenospongine 195 
 
5-epi-nakijiquinone U 191    
 
5-epi-nakijiquinone T 192    
Table 5. Meroterpenoids with a HQ fragment. 
  
R1 R2 R3 Name  R1 R2 R3 Name  
H H  avarol 196 H H H neoavarol 197 
Ac H H 17-O-acetylavarol 198 Ac H H 17-O-acetylneoavarol 199 
H H 
 
dysivillo n A 200 H H 
 
dysivillo n B 201 
H 
 
H dysivillosin C 202 H 
 
H dysivillosin D 203 
  
d i i l si
Mar. Drugs 2018, 16, x FOR PEER REVIEW  18 of 52 
 
 
sme ospongiarine 179 
 
langcoquinone D 186 
    langcoquinone E 187 
Table 4. Meroterpenoid analogues of avarone or neoavarone with a cis-decaline. 
  
R Name  R Name  
 
5-epi-nakijiquinone N 188 OEt 5-epi-20-O-ethylsmenoquinone 193 
 
5-epi-nakijiqui o  Q 189 NH2 5-epi-s nospong ne 194 
 
5-epi-nakijiquinone S 190  N-methyl-5-epi-smenospongine 195 
 
5-epi-nakijiqui one U 191    
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Most of the compounds included in this group were isolated from marine sponges and the first 
sesquiterpenequinone/HQ; Marcos et al. [6] gave the name “avarane” to the sesquiterpene skeleton 
for this reason. Avarone (139) (Table 1)/avarol (196) (Table 5) were isolated from the marine sponge 
Dysidea avara [74]. Since then, many other avarane TQs/THQs have been isolated from this and other 
marine sponge genus and species. 
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(−)-19-ethoxyneoavarone (159) (Table 2). Both pairs of compounds had a trans-decaline, but they 
belonged to the enantiomeric series; 223 and 224 are the only TQs, in this group, with their 
configurations shown in Figure 20. In the same study, the four new THQs dysiquinols A-D (240–243) 
(Figure 21) were also characterized. They had an oxygen bridge between the decaline and the 
aromatic core, forming a doubly fused pyran or oxepane ring [75]. They were tested against 
NCI-H929 melanoma cell line, and for their NF-κB inhibitory activity. All of them were cytotoxic, 
but only dysiquinol D (243) showed NF-κB inhibitory activity [75]. 
Amino-substituents on the quinone core were frequent in this meroterpenoid group. Thus, 13 
new sesquiterpene aminoquinones, along with six known ones, were isolated from Dysidea fragilis, 
collected along the coast of Yongxing Island in the South China Sea. The new compounds called 
dysidaminones A-M (141–147, 160–165) (Tables 1 and 2) were evaluated for their cytotoxicity, and 
for NF-κB inhibitory activity. Preliminary structure-activity relationship analysis showed that 
compounds with the Δ4(14) double bond in the decaline were much more potent on both activities 
than the others [76]. 
From Dysidea villosa, collected also at Yongxing Island in the South China Sea, several HQs with 
unprecedented pyridone substituents were isolated. They were called dysivillosins A-D (200–203) 
(Table 5), and they were evaluated for their anti-allergic activity. Interestingly, all four compounds 
could down-regulate the production of LTB4 and IL-4 in mast cells, with dysivillosin A (200) being 
the most potent agent [77]. 
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2) derivatives were isolated along with the known compounds arenarol (229) and popolohuanone A 
(227), having cis-decalines (Figure 20). The new derivatives were 18-aminoarenarone (167), 
19-aminoarenarone (168), 18-methylaminoarenarone (169), 19-methylaminoarenarone (170) (Table 
2), and the dimeric popolohuanone F (228) (Figure 20). They were neither antibacterial nor cytotoxic, 
although popolohuanones A and F exhibited moderate potencies in scavenging the 
2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical [78]. 
From another Dysidea sp. collected at Chuuk Island in the Federal States of Micronesia, 
melemeleones C and D (171 and 172) (Table 2), containing a cis-decaline core and a taurine fragment, 
and aureol B (245) (Figure 21), a cyclic derivative of arenarol (229) (Figure 20), were isolated and 
evaluated as cytotoxic, antimicrobial, and inhibitory for Na+/K+-ATPase [79]. 
Three new avarol derivatives were isolated from a Dysidea sp. collected at Iriomote Island, 
Okinawa. They were named 17-O-acetylavarol (198), 17-O-acetylneoavarol (199) (Table 5) and 
avapyran (244) (Figure 21). In this study avarol (196), neoavarol (197) (Table 5), and 3′-aminoavarone 
(140) (Table 1) were also isolated. By acylation and methylation reactions, several semisynthetic 
derivatives of avarol and neoavarol were obtained and evaluated as inhibitors of protein tyrosine 
phosphatase 1B (PTP1B), an enzyme related to glucose metabolism. In general, the avarol-type 
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Most of the compounds included in this group were isolated from marine sponges and the first
sesquiterpenequinone/HQ; Marcos et al. [6] gave the name “avarane” to the sesquiterpene skeleton
for this reason. Avarone (139) (Table 1)/avarol (196) (Table 5) were isolated from the marine sponge
Dysidea avara [74]. Since then, many other avarane TQs/THQs have been isolated from this and other
marine sponge genus and species.
In fact, genus Dysidea is an abundant source of chemically diverse and biologically active
meroterpenoids. In addition to avarol (196) (Table 5), which was isolated from specimens
of D. avara collected at Xisha Islands in the South China Sea, (+)-18-ethoxyavarone (223) and
(+)-19-ethoxyavarone (224) (Figure 20) were isolated, along with (−)-18-ethoxyneoavarone (158) and
(−)-19-ethoxyneoavarone (159) (Table 2). Both pairs of compounds had a trans-decaline, but they
belonged to the enantiomeric series; 223 and 224 are the only TQs, in this group, with their
configurations shown in Figure 20. In the same study, the four new THQs dysiquinols A-D (240–243)
(Figure 21) were also characterized. They had an oxygen bridge between the decaline and the aromatic
core, forming a doubly fused pyran or oxepane ring [75]. They were tested against NCI-H929 melanoma
cell line, and for their NF-κB inhibitory activity. All of them were cytotoxic, but only dysiquinol D
(243) showed NF-κB inhibitory activity [75].
Amino-substituents on the quinone core were frequent in this meroterpenoid group. Thus, 13 new
sesquiterpene aminoquinones, along with six known ones, were isolated from Dysidea fragilis, collected
along the coast of Yongxing Island in the South China Sea. The new compounds called dysidaminones
A-M (141–147, 160–165) (Tables 1 and 2) were evaluated for their cytotoxicity, and for NF-κB inhibitory
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activity. Preliminary structure-activity relationship analysis showed that compounds with the ∆4(14)
double bond in the decaline were much more potent on both activities than the others [76].
From Dysidea villosa, collected also at Yongxing Island in the South China Sea, several HQs with
unprecedented pyridone substituents were isolated. They were called dysivillosins A-D (200–203)
(Table 5), and they were evaluated for their anti-allergic activity. Interestingly, all four compounds
could down-regulate the production of LTB4 and IL-4 in mast cells, with dysivillosin A (200) being the
most potent agent [77].
The purple-coloured encrusting Dysidea sp. collected off the coral-reef near Yongxing Island in the
South China Sea, mentioned above for being a source of drimane meroterpenoids, was also a source of
avarane aminoquinone derivatives with a ∆4(14) double bond in a trans-decaline: smenospongine (176),
smenospongorine (178), smenospongiarine (179), smenospongidine (180), and the new derivative
smenospongimine (177) (Table 3). All of them showed potent antibacterial activities [66].
From a Dysidea sp. collected at Scott Reef, Northwest Australia, several arenarone (166) (Table 2)
derivatives were isolated along with the known compounds arenarol (229) and popolohuanone
A (227), having cis-decalines (Figure 20). The new derivatives were 18-aminoarenarone (167),
19-aminoarenarone (168), 18-methylaminoarenarone (169), 19-methylaminoarenarone (170) (Table 2),
and the dimeric popolohuanone F (228) (Figure 20). They were neither antibacterial nor
cytotoxic, although popolohuanones A and F exhibited moderate potencies in scavenging the
2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical [78].
From another Dysidea sp. collected at Chuuk Island in the Federal States of Micronesia,
melemeleones C and D (171 and 172) (Table 2), containing a cis-decaline core and a taurine fragment,
and aureol B (245) (Figure 21), a cyclic derivative of arenarol (229) (Figure 20), were isolated and
evaluated as cytotoxic, antimicrobial, and inhibitory for Na+/K+-ATPase [79].
Three new avarol derivatives were isolated from a Dysidea sp. collected at Iriomote Island,
Okinawa. They were named 17-O-acetylavarol (198), 17-O-acetylneoavarol (199) (Table 5) and avapyran
(244) (Figure 21). In this study avarol (196), neoavarol (197) (Table 5), and 3′-aminoavarone (140)
(Table 1) were also isolated. By acylation and methylation reactions, several semisynthetic derivatives
of avarol and neoavarol were obtained and evaluated as inhibitors of protein tyrosine phosphatase
1B (PTP1B), an enzyme related to glucose metabolism. In general, the avarol-type meroterpenoids
appeared to be better inhibitors than the neoavarol ones; however, 17-O-acetylneoavarol (199) was the
most potent PTP1B inhibitor in this study [80].
A new sesquiterpenoid HQ, 19-hydroxypolyfibrospongol B (208) was isolated from the marine
sponge Dysidea arenaria collected off Hainan Island in South China Sea, along with the known
compounds polyfibrospongol B (206) (Table 6), ilimaquinone (174), and smenospongine (176)
(Table 3). All were evaluated for their in vitro anti-HIV activity on HIV-RT, with the finding that
polyfibrospongols were inactive, whereas the quinones displayed moderate inhibitory activity [81].
Kobayahsi et al. performed several chemical composition studies on collections of marine
sponges of the family Spongiidae collected off the Unten Port, Kerama Islands, and Gesahi, Okinawa,
from which many sesquiterpenoid quinones containing amino substituents were isolated and given
the generic name of nakijiquinones. The first compounds of this family, nakijiquinones A–D were
described before [82,83], and nakijiquinones E–S were isolated during the period covered by this
review. Nakijiquinones E and F (230 and 231) (Figure 20) are pseudodimeric meroterpenoids from
sponge SS-1037 that did not show cytotoxicity against murine leukemias P-388 and L1210, and KB
human epidermoid carcinoma [84]. Nakijiquinones G–I (153–155) (Table 1) from collections SS-1074
and SS-1047, had residues of histamine, agmatine, and methylsulfinylpropanamine respectively,
being modestly cytotoxic against the same cell lines. They exhibited inhibitory activity on HER2
kinase, and antimicrobial and antifungal activities [85]. From collections SS-1047, SS-265 and SS1208,
nakijiquinones K, L, N, O, Q, and R, (149, 181, 150–152 and 156) (Tables 1 and 3), were isolated,
having 2-methylbutylamine, isopentylamine, isobutylamine, phenetylamine, and taurine residues
attached to the quinone ring. Nakijiquinones J, M, and P have an aureane skeleton and nakijiquinones
Mar. Drugs 2018, 16, 292 22 of 52
N, O, and R showed inhibitory activity against HER2 tyrosine kinase [67]. From collection SS-1202,
nakijiquinone S (148) (Table 1), with a n-butoxy substituent, and the o-hydroquinone derivative
nakijinol C (204) (Table 6) were isolated, displaying antimicrobial activities against several bacteria
and fungi [86].
Almost simultaneously, the same generic names were used by Daletos et al. for different
meroterpenoids isolated from the sponge Dactylospongia metachromia, collected at Ambon,
Indonesia [87]. The sesquiterpene quinones isolated from D. metachromia had a cis-decaline, so that
the authors used the 5-epi-nomenclature, even though the corresponding trans isomers were not
known by the authors at that time. This has led to the fact that nakijiquinone S (148) (Table 1)
and 5-epi-nakijiquinone S (190) (Table 4) do not differ only in the configuration at C-5, as it
should be, but also in the aminosubstituent on the quinone ring. Even greater are the differences
between nakijinol C (204) (Table 6) and 5-epi-nakijinol C (221) (Table 7), the latter having an
oxazole ring fused to the quinone moiety. Other new sesquiterpenoid quinones isolated from D.
metachromia were 5-epi-nakijiquinone Q (189), 5-epi-nakijiquinone T (192), 5-epi-nakijiquinone U (191),
5-epi-nakijiquinone N (188) (Table 4), and the oxazolobenzoxazole 5-epi-nakijinol D (222) and the known
18-hydroxy-5-epi-hyrtiophenol (219) (Table 7). All of the quinones showed pronounced cytotoxicity,
while the benzoxazoles showed a significantly lower cytotoxicity; they were also tested on a panel of
16 protein kinases involved in the regulation of tumor growth and metastasis, with similar results [87].
The benzoxazole nakijinol B (214) (Table 7) was described earlier from Dactylospongia elegans,
collected at the northeast of Truant Island, Australia, together with the new meroterpenoids
smenospongine B (183) and smenospongine C (184), and the already-known ilimaquinone (174)
(Table 3) and dactyloquinone B (234) (Figure 21) [88]. They were found to have moderate to good
cytotoxic activities on a panel of human tumor cell lines [88]. From the same species D. elegans,
though collected off the coast of Palau, as mentioned before, several meroterpenoid quinones with
diverse sesquiterpene skeletons were also isolated. In addition to ilimaquinone (174), among those
with an avaranyl moiety were: 5,8-diepi-ilimaquinone (225), 4,5-diepi-dactylospongiaquinone (226)
(Figure 20), 8-epi-dactyloquinone B (237), and 10,17-O-cyclo-4,5-diepi-dactylospongiaquinone (239)
(Figure 21) [65]. Compounds 237 and 239 displayed a quite a unique trans configuration for the methyl
groups at C-8 and C-9. All of these compounds from D. elegans were cytotoxic, and in addition,
ilimaquinone (174), 5,8-diepi-ilimaquinone (225), and 4,5-diepi-dactylospongiaquinone (226) activated
hypoxia-inducible factor-1 (HIF-1), and increased the expression of HIF-1 target vascular endothelial
growth factor (VEGF) gene in T47D cells, representing potential drug leads for the prevention and/or
treatment of ischemic disorders [65]. The opposite effect of hypoxia-selective growth inhibitory activity
against DU145 cells was described for HQ dictyoceratin A (smenospondiol, 210) (Table 6), either for the
natural product isolated from D. elegans [89], and for the two (+) and (−)-synthetic enantiomers [90].
From a marine sponge Spongia sp., collected off Son Cha, Vietnam, many sesquiterpene
aminoquinones/HQs were isolated by Morita et al. [91–93]. The aminoquinones were called
langcoquinones A-F (177, 185, 175, 186, 187, 182) (Table 3), and the HQs were called langconols A–C
(211–213) (Table 6). They were assessed for antibacterial activities, being inactive against Gram-negative
bacteria but being selectively active on Gram-positive bacteria. Some of them also showed significant
cytotoxicity against several human cancer cell lines. Other sesquiterpene quinones already known
and isolated from this Vietnamese Spongia sp. were dictyoceratin A (210), polyfibrospongol A
(205), polyfibrospongol B (206), 19-hydroxypolyfibrospongol B (208) (Table 6), ilimaquinone (174),
smenospongine (176), smenospongidine (180), smenospongorine (178), and nakijiquinone L (181) (Table 3).
It is necessary to mention that, as has happened before, the same compound was isolated almost
simultaneously from different sources and received different names. Thus, the first compound of
the above family, langcoquinone A (177) (Table 3) [91], bearing a methylamino group, has the same
structure given for smenospongimine, isolated from Dysidea sp. [66].
New avarane-HQs, named smenohaimiens C–E (217, 207, 209) (Tables 6 and 7), were isolated
from the sponge Smenospongia cerebriformis, along with polyfibrospongol A (205), polyfibrospongol B
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(206), 19-hydroxypolyfibrospongol B (208) (Table 6), and ilimaquinone (174) (Table 3) [94]. They were
moderate inhibitors of nitric oxide production in lipopolysaccharide-stimulated BV2 microglia cells,
obtaining the best results with ilimaquinone.
From the sponge Spongia pertusa, collected off the coast of Yongxing Island, China,
several sesquiterpene quinones were described by the first time, either with cis- and trans-decalines,
and even from the enantiomeric series such as N-methyl-ent-smenospongine (ent-177) (Table 3) and
N-methyl-5-epi-smenospongine (195), along with the known 5-epi-smenospongine (194) (Table 4),
smenospongine (176), and smenospongiadine (180) (Table 3). From the same sponge, new analogues
with an additional pyran ring were also identified as 20-demethoxy-20-methylaminodactyloquinone
D (235), 20-demethoxy-20-methylamino-5-epi-dactyloquinone D (236), and 20-demethoxy-20-
methylaminodactyloquinone B (238) (Figure 21) [95].
It has been reported that ethylsmenoquinone (173) and ilimaquinone (174) (Table 3) exhibited
antiproliferative activity on multiple myeloma cells by down-regulating the expression of the
oncogenic protein β-catenin [96]. In other to obtain new derivatives with such property, new avarane
sesquiterpenequinones were generated by biotransformations of the meroterpenoids typically isolated
from Smenospongia sponges, using the strong oxidative potential of the sponge Verongula rigida. Thus,
Smenospongia aurea and S. cerebriformis were homogenized and incubated with V. rigida generating
several new meroterpenoids such as (+)-5-epi-20-O-ethylsmenoquinone (193) (Table 4) and the
benzoxazoles (−)-nakijinol E (215), (+)-5-epi-nakijinol E (216) (Table 7), and a mixture of nakijinone A
and 5-epi-nakijinone A (232) (Figure 20). As the accumulation of intracellular β-catenin is also important
in the development and progression of colorectal cancer, they were evaluated against two β-catenin
response transcription (CRT)-positive colon cancer cell lines, and it was found that they were able to
suppress CRT by promoting the degradation of β-catenin, with (+)-5-epi-20-O-ethylsmenoquinone
(193) (Table 4) being the most potent compound [97].
Nakijinols B (214) (Figure 21) and E (215) (Table 7) were also identified from a Hyrtios sp. sponge
collected off Yongxing Island in the South China Sea, from which two new benzoxazole analogues
named nakijinol F (217) and nakijinol G (218) (Table 7) were isolated, and it was found that nakijinol G
(218) showed PTP1B inhibitory activity, but no cytotoxicity against four human cancer cell lines [98].
Again, the structure described for nakijinol F was identical to that of smenohaimien C isolated from
the sponge S. cerebriformis [94]. Nakijinols A (220), B (214), and E–G (215, 217, and 218) (Table 7)
were efficiently synthesized recently by Takeda et al., starting from smenospongine (176) (Table 3),
with confirmation of their absolute configurations [99].
Several derivatives of ilimaquinone were also obtained through biotransformation in the presence
of the mold fungus Mucor circinelloides, which induced a stereospecific β-epoxidation of the exocyclic
∆4(14) double bond by the most hindered face, compared with chemical epoxidation that led to the
α-isomer as the major one. Hydroxylation of the decaline at C-3 was also detected, as well as an
unexpected substitution on the quinone ring by ethanolamine. None of these compounds showed
antiproliferative effect against three human cancer cell lines [100].
Total synthesis of (+)-avarone (139) (Table 1), (+)-avarol (196) (Table 5), (−)-neoavarone (157)
(Table 2), (−)-neoavarol (197) (Table 5), and (+)-aureol B (245) (Figure 21) was efficiently performed
by Sakurai et al. from (+)-5-methyl-Wieland-Miescher ketone. In vitro cytotoxicity assays on human
lymphoma cells U937 showed that quinone derivatives were more potent than the corresponding HQs,
and also that the position of the olefinic double bond has a large effect on activity, being better those
quinones with an exocyclic double bond in the decaline [101].
4.3.4. Other Bicyclic Sesquiterpenoids
Another sesquiterpenoid skeleton resulting from a different rearrangement of the initial drimane
skeleton is bolinane. The representative TQ of this group is bolinaquinone (246) (Figure 22),
isolated first in 1998 from a Philippine sponge Dysidea sp., and showing relevant anti-inflammatory
properties by the inhibition of phospholipase (PL) A2 [102]. It significantly reduced the production
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of mediators in the inflammatory processes, and it modulated oxidative stress. Several mechanistic
studies suggested a competitive inhibition of PLA2 guided by a non-covalent molecular recognition
event [103]. Because of these interesting results, a series of simplified analogues of bolinaquinone were
developed, changing the sesquiterpenyl core by other rings, and the in vitro assay indicated that all
compounds inhibited PGE2 production with different potencies [104].
Other merosesquiterpenoids with a bolinane skeleton were 21-dehydroxybolinaquinone (247),
isolated from the Hainan sponge D. villosa, along with bolinaquinone (246) and dysidine (249)
(Figure 22). The three compounds showed inhibitory activity of hPTP1B, a potential target for treatment
of type-II diabetes and obesity [105].
Dysideamine (248) (Figure 22) was isolated, along with bolinaquinone (246), from an Indonesian
sponge of Dysidea sp. Both compounds showed neuroprotective effects in mouse HT22 hippocampal
neuronal cells, and dysideamine (248) inhibited the production of ROS [106].
A different rearrangement of the sesquiterpenoid skeleton led to a 6–7 carbocyclic framework
as in frondosins (frondosin A, 250) or liphagal (251) (Figure 22). Although these compounds were
described before the period covered by this review, several synthetic studies have been performed
during this time to clarify conflicting assignments on some stereocentres [107–109]. These were well
compiled in the Wright’s review [108].
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Many other cyclization patterns were described, having additional C–C bonds between the
sesquiterpenic decaline and the aromatic fragments, giving rise to tetracyclic meroterpenoids after the
formation of an additional cyclopentene or cyclohexene ring, as those described below.
The formation of a new C–C bond between the quinone and the C-1 position of the
avarane-derived decaline generates the unprecedented 6-6-6-6-fused benzoanthracene skeleton found
in dysideanones A and B (252 and 253) (Figure 23), isolated from the South China Sea sponge D. avara
collected at Yongxing Island, China [110]. From the same specimen, another unusual 6-6-5-6-fused
benzofluorene core was found in dysideanone C (254) (Figure 23), in which the additional C-C bond
was formed between the quinone and the decaline C-8 position. None of the three compounds showed
any antibacterial or antifungal activity, and only dysideanone B (253) was cytotoxic. It was postulated
that avarol (196) (Table 5) could be their biosynthetic precursor [110].
Dysifragilones A-C (255–257) (Figure 23) are other examples of the same 6-6-5-6-benzofluorene
core isolated from Dysidea fragilis collected at the same place, Yongxing Island, and bearing amino
substituents on the quinone fragment. They displayed potential anti-inflammatory activity through
the inhibition of NO production in mouse macrophages, with dysifragilone A being the most potent
compound [111].
A different benzofluorene skeleton was described by the first time in cycloaurenones A–C
(258–260) (Figure 23), isolated from a tropical Dysidea sp. collected at Chuuk Island in the Federal
States of Micronesia. In these compounds, the five-membered ring was formed by a direct C-C linkage
between the position C-10 of the avarane-type decaline and the quinone moiety. They exhibited
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cytotoxic activities comparable to that of doxorubicin. Melemeleones C and D (171 and 172) (Table 2)
described above were also isolated from the same specimen [79].
With the same 6-6-5-6-fused tetracyclic carbon skeleton, but derived from HQs, are the dysiherbols
A-C (261–263) (Figure 23), also isolated from a Dysidea sp. collected at Xisha Islands in the South China
Sea [112]. Evaluation of their NF-kB inhibitory activity and their cytotoxicity disclosed that dysiherbol
A (261) was several times more potent than the other two, highlighting the negative influence of
oxygen functions at C-3 of the decaline. From the same specimen, dysideanone E (264) (Figure 23),
with the same benzoanthracene as mentioned above, was also isolated [112].
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A different 6-membered ring was formed when the new C–C bond linked the aromatic core
to the C-12 methyl of a drimane decaline. This happened in alisiaquinones A–C (265–267), and in
alisiaquinol (268) (Figure 24), which was isolated from an unidentified New Caledonian deep water
sponge. The new 6-membered ring was aromatized, forming benzo[a]anthracenequinones. The higher
oxidation degree of the decaline core allowed the formation of an additional tetrahydrofuran ring.
These meroterpenoids displayed in vitro and in vivo antimalarial activity on P. falciparum strains,
being good inhibitors of two malarial targets, the plasmodial kinase Pfnek-1 and a protein farnesyl
transferase [113].
The same carbon skeleton was also present in neopetrosiquinones A and B (269 and 270)
(Figure 24), isolated from the deep-water sponge Neopetrosia cf. proxima, collected off the north coast
of Jamaica [114]. Their enantiospecific synthesis have been performed by Chayboun et al. from the
labdane diterpenoid trans-communic acid. They showed moderate cytotoxicity against a panel of
tumor cell lines and were able to induce apoptosis [115].
A different 6-6-6-6-tetracyclic carbon skeleton, resulting from cyclization of the quinone core on
the C-7 position of the avarane, was found in dysidavarones A–D (271–274) (Figure 25), and was given
the name of dysidavarane. They were isolated from the sponge D. avara, which was collected off the
Xisha Islands by Lin’s group, who proposed that they might be generated biogenetically from avarone
and neoavarone. These compounds were cytotoxic for four tumor cell lines, and dysidavarones A (271)
and D (274) were also inhibitors of PTP1B [48]. Because of their unusual structure, dysidavarone A
(271) has been the objective of several total syntheses performed by different research groups [116–118].
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Figure 24. Structure of tetracyclic merosesquiterpenoids 265–270.
There are other polycyclic meroterpenoids with rearranged skeletons, such as rossinone B (275) and the
three NQ derivatives 276–278 (Figure 25), isolated from Antarctic colonial ascidians of the genus Aplidium,
such as Aplidium fuegiense collected in the Western Weddell Sea, Antarctica [8,119,120]. Rossinones were
allocated in the internal tissues of the ascidians, and showed significant feeding-deterrent activity
against invertebrate predators and bacterial fouling, revealing their role in predation avoidance [119,120].
A biomimetic highly efficient total synthesis of rossinone B (275) was performed by Zhang et al. [121].
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5. Meroterpenoids with Open-Chain and Cyclic Diterpenoids
5.1. Open-Chain Diterpenoids
Open-chain diterpenoids are well known and widely distributed in nature, and tocopherols or
plastoquinones belong to this group of structures.
These kinds of meroditerpenoids are abundant in brown algae (Phaeophyceae). Among them,
the genus Sargassum (Sargassaceae) has b en highly studied as ource of tetraprenyl-toluquinols,
toluquinones, and chromenols, and they have been reported to display a range of biological activities,
as described in previous reviews [1,3].
From the species Sargassum sagamianum, collected at Manazuru (Japan), Horie et al. isolated
two new toluquinones with δ-lactones in their tetraprenyl side chains (279 and 280), along with the
plastoquinone sargaquinoic acid (281) (Figure 26), which was postulated to be epoxidized at ∆14
′
of
the side chain, followed by cyclization [122]. Moreover, in the same study, the authors obtained the
chromene derivatives 12′-hydroxysargachromelide (282), chromequinolide (283), and sargachromenol
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(284) (Figure 26), which were considered as artefacts because of their lack of optical activity.
One interesting ketone that was probably formed by oxidative cleavage was compound 285 (Figure 26),
which showed the best results from in vitro assays as an antibacterial against S. aureus, and as a
cytotoxic compound against HeLa S3 cells.
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Figure 26. Structures of open-chain meroditerpenoids and related compound 279–285.
Sargaquinoic acid and sargachromenol displayed an apoptotic effect in vitro and in vivo,
which was enhanced in combination with ultraviolet-B irradiation by caspase activation.
This combination could be effective as a therapeutic agent against hyperproliferative diseases of
skin, such as psoriasis [123].
Also from the coasts of Japan (Toyama Bay), Iwashima et al. isolated from Sargassum micracanthum
two new chromane derivatives (286 and 287) (Figure 27) [124]. Their absolute stereochemistries were
determined by a modified Mosher’s method through its known 10′R-hydroxy derivative, which was
also used as semisynthetic precursor of 286 through the reduction of the 10′R-acetoxy derivative with
SmI2/HOAc.
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From Sargassum siliquastrum collected near Jeju Island (South Korea), Jung et al. obtained
the antioxidant sargahydroquinoic acid (288), along with the new analogue 289 with an unknown
stereochemistry, and compound 290, a derivative related to a modified tetraprenyl dihydroquinone,
which is unprecedented within algal metabolites (Figure 28) [125].
Compound 290 could be a biosynthetic precursor of nahocols and isonahocols (Figure 29) by a
1,3-migration of its methyl acetate group. Although the biogenetic relation is unclear, this hypothesis
was supported because in the same study, eight new (291–298) (Figure 29) and eight known
meroditerpenoids of the nahocol and isonahocol classes were isolated. Diphenolic isonahocol
compounds showed a 100-fold increase in radical-scavenging activity relative to monophenolic
nahocols [125].
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In southern Australia (Port Phillip Bay), Reddy and Urban collected another species of this genus,
Sargassum fallax, from which they isolated fallahydroquinone (299), fallaquinone (300, an artefact
formed after exposure to air) and fallachromenoic acid (301), along with sargaquinone (302) (Figure 30),
sargaquinoic acid (281) (Figure 26), and other known derivatives [126]. These new meroditerpenoids
showed IC50 valu s around 27–29 µM agai st P-388 mu ine leukaemia c lls. Their stereochemistry
could not be assigned due to the rapid decomposition of the compounds isolated. In our opinion,
allylic δ-chlorocarboxylic acid moieties like those present in fallachromenoic acid (301), could be
precursors of δ-lactones related to sargachromelides (Figure 26).Mar. Drugs 2018, 16, x FOR PEER REVIEW  29 of 52 
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Again Urban, together with Brkljača, described four new meroditerpenoids isolated after an
antimicrobial-guided investigation from Sargassum paradoxum from the same sea waters, in addition to
other known tetraprenyl analogues, among them, the main constituents being fallahydroquinone (299)
(Figure 30) and sargahydroquinoic acid (288) (Figure 28) [127]. They used stop-flow high-performance
liquid chromatography (HPLC)-nuclear magnetic resonance (NMR) and HPLC-mass spectrometry
(MS) to characterize paradoxhydroquinone (303), paradoxquinone (304), paradoxquinol (305), and the
unstable sargahydroquinal (306) (Figure 31).
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The last species of this genus reviewed in this part is Sargassum yezoense, which collected in the
eastern coast of South Korea by Kim et al. [128]. They described four new plastoquinones designated
as meroterphenols A–D (307–310) (Figure 32), which showed potent activation effects on peroxisome
proliferator receptor gamma (PPARγ), so they might have anti-diabetic potential via the transactivation
of this receptor.
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In the same family Sargassaceae, the genus Cystoseira with nearly 300 species has been an
important source of bioactive tetraprenyltoluquinols [129].
In two different samples of Cystoseira usneoides, one collected at Gibraltar Strait along the
Mediterranean coast of Morocco [42] and another at the coast of Tarifa (Spain) [130], de los Reyes
et al. isolated 10 cystodiones (311–319 and 328) and six cystones (326, 327, 329, 330, 333/334,
and 335), that were new toluquinol and O-methyltoluquinol diterpenoids with different oxygenated
functionalities and unsaturations along the diterpenoid backbone, besides other known analogues
(320–325) (Figure 33). All of them showed antioxidant activity in the ABTS radical-scavenging assay.
Moreover, the significant activity of 317, 319, 322, 323, and 329 as inhibitors of the production of
Mar. Drugs 2018, 16, 292 30 of 52
the proinflammatory cytokine TNF-α in LPS-stimulated THP-1 macrophages (human monocytic
leukaemia cells) support the potential of these products for usage as anti-inflammatories [130].
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From Cystoseira abies-marina collected off Sao Miguel Island, Azores (Portugal), two other 
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and were called cystoazorols A and B (331 and 332) (Figure 33) [41]. 
Moreover, from this species of Cystoseira, four new ketones with only 14 carbon atoms at the 
terpenyl chain were isolated. They probably derived from the oxidative degradation of the 
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Cystoazorones A and B (338 and 339) (Figure 34) are also Δ6 stereoisomers, and they showed 
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From Cystoseira abies-marina collected off Sao Miguel Island, Azores (Portugal), two other
analogues that were completely methylated at the toluquinol motif were obtained by Gouveia et al.,
and were called cystoazorols A and B (331 and 332) (Figure 33) [41].
Moreover, from this species of Cystoseira, four new ketones with only 14 carbon atoms at the
terpenyl chain were isolated. They probably derived from the oxidative degradation of the diterpenoid
side chain. Cystodiones C and D (336 and 337) (Figure 34) differ in the configuration of ∆6, and can be
considered to be derived from cystodiones A and B (311 and 312, Figure 33) [42]. Cystoazorones A
and B (338 and 339) (Figure 34) are also ∆6 stereoisomers, and they showed moderate antioxidant and
anti-inflammatory activities [41].
Another marine brown algae, Stypopodium flabelliforme (Dictyotaceae) was collected in Easter
Island (Chile) by Areche et al., and after acetylation of the extract, tetraprenylhydroquinone diacetate
340 (Figure 35) was isolated [131]. It was described by the authors as a new natural product, although
it was synthesized many years ago in investigations on the biosynthesis of α-tocopherols in spinach
chloroplasts [132]. From the same peracetylated extract, the known diacetylated geranylgeranyl
analogue 341 and its acetylchromenol derivative 343 were isolated (Figure 35), along with some
tricyclic meroditerpenoids, which are presented later in Section 5.4. Six years later, the same group
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published the gastroprotective effects of sargaol (342) (Figure 35) in a mouse model, which was
attenuated with indomethacin and N-ethylmaleimide, suggesting that prostaglandins and sulfhydryl
groups are involved in its mode of action. Sargaol (342) was obtained after hydrolysis of the acetylated
derivative 343 [133].Ma . Drugs 2018, 16, x FOR PEER REVIEW  31 of 52 
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Diterpenylquinones nd d riv tives were als isolated from other marine organisms differe t from
b wn algae, such as ascidians, sponges or soft corals, all belonging to the animal kingdom. From the
scidian B tryllus tub r tus, two new epimeric γ-lactones, tuberatolide B (344) and 2′-epi-tuberatolide
B (345) (Figure 36) were isolated [134]. The co-isolation in equivalent amounts of both chromenols
suggests that they could have originated as artefacts from the known quinone yezoquinolide (346)
(Figure 36), which was also isolated from this Korean marine tunicate, along with the two separated
enantiomers of sargachromenol (284) (Figure 26). As these last compounds had already been
described in different brown algae of genus Sargassum [135,136], it would be possible that symbiotic
microorganisms in brown algae and tunicates synthesized these terpenoids or alternatively, that the
source organisms may have similar biosynthetic genes. These tuberatolides were potent (1.5–2.5 µM)
antagonists of chenodeoxycholic acid-activated human farnesoid X receptor (hFXR), and this fact may
help to unravel the controversial function of FXR in atherosclerosis.
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During a big program for discovering new anticancer agents, the group of Capon described
the new meroterpenoids fascioquinol E (347) and fascioquinol F (348) from an Australian sponge,
Fasciospongia sp., along with the known geranylgeranyl-HQ 349 (Figure 37), which was the dominant
cytotoxic compound of the ethanolic extract of this sponge [137]. They proposed both tetraprenyl-HQs
as the acid-mediated biosynthetic precursors of the tricyclic fascioquinols, which are described later.
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From a soft coral collected off the South China Sea, Sarcophyton infundibuliforme, Wang et al.
isolated α-tocopherylquinone 350 (Figure 38), which was quite rare in marine materials [138]. Also,
from another soft coral, the Formosan Lobophytum crassum, crassumtocopherols A (351) and B (352)
(Figure 38) were obtained, these two new α-tocopherols having moderate cytotoxicity against P-388
cells [139].
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5.2. Monocyclic Diterpenoids
In addition to the open-chain meroditerpenoids of the nahocol class from S. siliquastrum mentioned
above [125], isolation was made for compound 353 (Figure 39), which had a cyclopentenone tetraprenyl
chain. Only one natural compound has previously shown this cyclization pattern in brown algae,
sargachromanol P (354) (Figure 39), a chromane meroterpenoid that was isolated from the same
species [140].
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A new carbon skelet n was fou for halioxepine (355) (Figure 39), a HQ with a diterpenic motive
containing a cyclohexene and another additional epin ring, i olated from Haliclona sp., an Indonesian
sponge. It showed moderate cy otoxicity against NBT-T2 c lls (rat bladder epithelial carci oma) [14 ].
Only the relative configuration of the stereocenters in each ring, 1, 2 and 7, and 10 and 15, was assigned.
l st i l
4′ (Figure 40) was isolated.
three distinct units: a diterpene linked to a O-methyltoluquinol and a phloroglucinol. Although
terpenyl-phloroglucinols are well known [143], these hybrids are the first examples of meroterpenoids
with a 2,7-dioxabicyclo[3.2.1]octane backbone fused to a phloroglucinol.
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5.3. Bicyclic Diterpenoids
Four new bicyclic diterpenoids linked to a HQ derivative (362–365) (Figure 41) were isolated by
okrini et al., from Cystoseira baccata harvested along the Atlantic coasts of Morocco [144]. The absolute
configuration was deduced by application of modified Mosher’s method through the hydroxy
derivative at C-12. The stereostructure of the hydrindane system of these compounds revealed a trans
orientation of their two bridgehead methyls, instead of the cis orientation of compounds previously
reported from Cystoseira genus as 1′-demethylcystalgerone (366) and its chromanol derivatives
(368 and 369) (Figure 41) [145,146]. On the basis of the NMR data and optical activity comparisons,
Mokrini et al. [144] postulated the hypothesis that the compounds related to cystalgerone (367) were
isolated at least from the species C. baccata [147,148], would possess a trans-fused configuration.
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In a study on intraspecific variation of meroditerpenoid production carried out at four different
populations of Brazilian brown alga Stypopodium zonale, three chemotypes were described through their
HPLC-DAD chemical profiles of their CH2Cl2 extracts. Along with the principal and known bicyclic
meroditerpene atomaric acid (370) and the tricyclic stypoldione, three new carbobicyclic compounds
(371–373) (Figure 42) were isolated and fully characterized by NMR and MS techniques [149]. It is the
first time that a compound with the furan-lactone moiety of stypofuranlactone (371) has been obtained
from marine brown algae.
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5.4. Tricyclic and Tetracyclic Diterpenoids
The strongylophorines are meroditerpenoids that were isolated by Braekman et al. for the
first time from the sponge Strongylophora durissima, actually belonging to genus Petrosia and
subgenus Strongylophora [150]. Several activities have been described in the last years for them,
as antibacterial, antifungal, insecticidal or cytotoxic against different cancer cells, among others.
From Petrosia (Strongylophora) strongylata collected off Milne Bay (Papua New Guinea), the known
strongylophorines-8, -2, and -3 (374–376) were isolated (Figure 43). They were responsible for the
inhibition of the HIF-1, considered as a crucial mediator in survival and progression of tumors [151].
The tricyclic diterpenoid, including the lactone fragment present in 374 and 375, was important for
HIF-1 inhibition.
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Figure 43. Structures of strongylophorines 374–376.
In the same species collected off Okinawa (Japan), the new 26-O-ethylstrongylophorine-14 (377)
(Figure 44) was isolated by Lee et al., along with several known compounds of this family, some of
them represented here (374–376, 378, 379) (Figures 43 and 44) [152]. Their activity as PTP1B inhibitors
was evaluated, being stronger for compounds that had an acetal moiety at C-26 than for those with a
lactone function.
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From the Indonesian sponge Petrosia corticata, 26-O-methylstrongylophorine-16 (378) and
26-O-ethylstrongylophorine-16 (380) were isolated (Figure 44), along with the known derivatives
374–376 and 381. Their inhibitory activity of the proteasome was tested, the acetals being the most
active compounds 377, 378, 380, and 381. Additionally, the HQs were more active than chromanols,
as happened with strongylophorine-14 (381) and its epimer at C-26, the hemiacetal position [153].
Beside the geranylgeranyl-HQ 349 and fascioquinols E and F (347 and 348) (Figure 37) mentioned
previously, from an Australian marine sponge, Fasciospongia sp., several tricyclic meroditerpenoids,
as the known strongylophorine-22 (382) and the new meroterpene sulfate fascioquinol A (383),
were isolated (Figure 45). A series of acid-mediated hydrolysis/cyclization products, fascioquinols
B–D (384–386) (Figure 45), were also isolated, and they were biosynthetically related to the open-chain
diterpenoids. Fascioquinols A and B (383 and 384) showed promising selective Gram-positive
antibacterial activity towards S. aureus and B. subtilis [137].
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The simultaneous presence of open-chain and tricyclic meroditerpenoids in the same organism
was also observed in S. flabelliforme, as mentioned before, and this could support the biogenetic
relationship between them. Meroterpenoids are usually isolated as their corresponding acetates,
to avoid the over-oxidation of the natural products. Thus, in addition to the acetylated meroterpenoids
340–343 described above (Figure 35), the known tricyclic epitaondiol, isoepitaondiol, stypodiol,
and 14-ketostypodiol diacetates (387–390), stypotriol triacetate (391), and the new 4′-chlorostypotriol
triacetate (392) (Figure 46) were isolated after acetylation of the extract [131]. The occurrence of
halogenated compounds is unusual in brown seaweed, and 392 was the first halocompound reported
in the Stypopodium genus.
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The acetylated derivative of seco-taondiol (393) (Figure 47), a new eroterpenoid with an
unprecedented in nature syn-cis-anti arrangement for the A/B/C ring system, was isolated from
S. flabelliforme, along with 10 known meroterpenoids, and it was evaluated as being gastroprotective;
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after hydrolysis of the acetates, it was the most active epitaondiol, isoepitaondiol, stypodiol (Figure 46)
and sargaol (342) (Figure 35) through different modes of action [133].
From S. zonale collected off distinct areas of the Brazilian coast, besides the bicyclic meroterpenoids
370–373 mentioned before (Figure 42), the known tricyclic stypoldione (394) (Figure 47) was also
isolated [149]. From the same S. zonale but collected off Jamaica, Penicooke et al. described the only
tetracyclic derivative reported in this period, zonaquinone acetate (395), along with stypoldione (394)
(Figure 47) and sargaol (342) (Figure 35). The tetracyclic diterpenoid was fused to a methylBQ and the
acetate was naturally present in the extract. It was assayed favorably as being antiproliferative against
MCF-7 breast cancer and HT-29 colon cancer cells [154].
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6. Meroterpenoids with Larger Terpenoids
Only three new sesterterpenoid HQs were discovered over these years, with two of them being
related to the bicyclic terpenoid halisulfate-1 (396) and the other to disidein (401), the latter presenting
a pentacyclic system in the terpene core (Figure 48).
Two new pentaprenyl bicyclic HQs, 12E-coscinoquinol (397) and 17Z-halisulfate-1 (398), and the
other three known compounds, halisulfate-1 itself (396), 12Z-coscinoquinol (399), and the sodium
salt of the coscinosulfate isomer 400, were obtained from a Micronesian (Chuuk Island) sponge,
Coscinoderma sp. (Figure 48) [155]. The sulfate-containing compounds were more potent than the
coscinoquinols as Na+/K+-ATPase inhibitors, and against sortase A, a key enzyme for the cell adhesion
of Gram-positive bacteria. However, coscinoquinols showed more potent inhibition than doxorubicin
against K562 cells, while the halisulfates were inactive.
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With scalarene skeleton, acanthosulf e (402) was de cribed as a new derivative of disidein (401)
(Figure 48), with different configuration at sever l ster ocenter [156]. It was isolated by We t and
Faulkner from a P lippine sponge, Acanthodendrilla sp., collected off Boracay Island. Acanthosulfa e
inhibited the proteasome function (IC50 4.5 µM); however, it lacked the sel ctivity and potency in the
BMS Oncology Diverse Cell Panel (ODCA) to be considered for in vivo evaluation.
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Finally, from different Mediterranean sponges, several all-trans polyprenylated HQs were isolated:
hexaprenyl-HQ (403) and nonaprenyl-HQ (406) from Sarcotragus muscarum [157], heptaprenyl-HQ
(404) from Ircinia fasciculata [157], and again 404, octaprenyl-HQ (405), and the new hydroxylated at
C-38 nonaprenyl-HQ 407 from Sarcotragus spinosulus [158] (Figure 49). Hexaprenyl-HQ (403) showed a
great cytotoxicity against H4IIE hepatoma cells and also resulted in potent inhibitors of EGFR tyrosine
kinase, among other kinases [157].
Mar. Drugs 2018, 16, x FOR PEER REVIEW  37 of 52 
 
H xaprenyl-HQ (403) showed a great cytotoxicity gainst H4IIE hepatoma cells and also resulted in 
potent inhibitors of EGFR tyrosine kinase, among other kinases [157]. 
 
Figure 49. Structures of polyprenylated HQs 403–407. 
7. Preparation of Bioactive TQs/HQs from Inactive Terpenoids 
As has been seen along this review, TQs/THQs are secondary metabolites with very interesting 
and sometimes unusual structural features, and also with a great variety of biological activities 
(anti-inflammatory, cytotoxic, antibacterial, antifungal, etc.), very often with difficult evaluation, 
due to the small amounts obtained from their natural sources, and even with difficulties for 
collecting again from the same organism. These facts have attracted scientific attention, and many 
efforts have been devoted to their synthesis, not only for confirming both the proposed structures 
and their absolute configurations, but also to obtain enough amounts to perform additional 
biological evaluations. 
Some of this kind of work has already been mentioned within this review, particularly that 
which deals with the total synthesis of the new TQs/THQs described here. Sometimes, the synthesis 
started from easily available small molecules such as the (+)-5-methyl Wieland-Miescher ketone 
used by Katoh et al. for the synthesis of several sesquiterpene quinones [159], or the Marshall’s 
decaline used by Kobayashi et al. in the synthesis of the akaterpin [160]. In other cases, natural 
products were used as the starting material. The strategies used in the synthesis of different 
TQs/THQs were the main subject of previous reviews [108,161], so this section is not intended to be 
exhaustive, but rather to focus in the idea of using natural products, particularly terpenoids, as the 
starting point to obtain a variety of bioactive analogues of marine natural products. 
A number of natural terpenoids obtained from their natural sources in enough quantity or 
industrial by-products with decaline cores, such as those that are present in the 
sesquiterpenequinones described here, can be used to synthesize many meroterpenoids. Using 
natural terpenoids has the advantage of starting from enantiopure compounds, so that single 
enantiomers can be obtained. Among those are (+)-sclareolide (Figure 50), a common feedstock in 
the perfume industry used by Baran et al. for the synthesis of 10 meroterpenoids with drimane 
skeletons [162]. Álvarez-Manzaneda et al. used (−)-sclareol, from Salvia sclarea (Fam. Lamiaceae), for 
the synthesis of akaol A [163]. Several ent-labdanes isolated from Calceolaria inamoena (Fam. 
Scrophulariaceae) were used by Catalan et al. for the synthesis of drimane-quinones [164], and 
ent-halimic acid, isolated from Halimium viscosum (Fam. Cistaceae), was used by Marcos et al. for the 
synthesis of several TQs with aureane skeleton (Figure 50) [165]. 
Natural terpenoids can also be used to obtain families of analogues that would allow for the 
performance not only different biological evaluations but also to analyze structure-activity 
relationships to establish the main structural features for a defined bioactivity, in order to design 
better drug candidates. 
Avarone (139) (Table 1) itself, which can be isolated in big quantities from D. avara, was used to 
obtain new non-natural alkyl(aryl)thio derivatives by nucleophilic addition of thiols or thiophenols 
to the quinone. It was found that they had similar cytotoxic activity than avarone but none of them 
showed better antibacterial activity than avarone (Figure 50). The cytotoxicity was enhanced by 
electron-donating substituents that lowered the one-electron reduction potential; however, the 
disubstitution led to a significant decrease in potency [166]. 
Figure 49. Structures of polyprenylated HQs 403–407.
7. Preparation of Bioactive TQs/HQs from Inactive Terpenoids
As has been seen along this review, TQs/THQs are secondary metabolites with very interesting
and sometimes unusual structural features, and also with a great variety of biological activities
(anti-inflammatory, cytotoxic, antibacterial, antifungal, etc.), very often with difficult evaluation, due to
the small amounts obtained from their natural sources, and even with difficulties for collecting again
from the same organism. These facts have attracted scientific attention, and many efforts have been
devoted to their synthesis, not only for confirming both the proposed structures and their absolute
configurations, but also to obtain enough amounts to perform additional biological evaluations.
Some of this kind of work has already been mentioned within this review, particularly that which
deals with the total synthesis of the new TQs/THQs described here. Sometimes, the synthesis started
from easily available small molecules such as the (+)-5-methyl Wieland-Miescher ketone used by Katoh
et al. for the synthesis of several sesquiterpene quinones [159], or the Marshall’s decaline used by
Kobayashi et al. in the synthesis of the akaterpin [160]. In other cases, natural products were used
as the starting material. The strategies used in the synthesis of different TQs/THQs were the main
subject of previous reviews [108,161], so this section is not intended to be exhaustive, but rather to
focus in the idea of using natural products, particularly terpenoids, as the starting point to obtain a
variety of bioactive analogues of marine natural products.
A number of natural terpenoids obtained from their natural sources in enough quantity or
industrial by-products with decaline cores, such as those that are present in the sesquiterpenequinones
described here, can be used to synthesize many meroterpenoids. Using natural terpenoids has the
advantage of starting from enantiopure compounds, so that single enantiomers can be obtained.
Among those are (+)-sclareolide (Figure 50), a common feedstock in the perfume industry used by
Baran et al. for the synthesis of 10 meroterpenoids with drimane skeletons [162]. Álvarez-Manzaneda
et al. used (−)-sclareol, from Salvia sclarea (Fam. Lamiaceae), for the synthesis of akaol A [163].
Several ent-labdanes isolated from Calceolaria inamoena (Fam. Scrophulariaceae) were used by
Catalan et al. for the synthesis of drimane-quinones [164], and ent-halimic acid, isolated from
Halimium viscosum (Fam. Cistaceae), was used by Marcos et al. for the synthesis of several TQs
with aureane skeleton (Figure 50) [165].
Natural terpenoids can also be used to obtain families of analogues that would allow for
the performance not only different biological evaluations but also to analyze structure-activity
relationships to establish the main structural features for a defined bioactivity, in order to design
better drug candidates.
Avarone (139) (Table 1) itself, which can be isolated in big quantities from D. avara, was used to
obtain new non-natural alkyl(aryl)thio derivatives by nucleophilic addition of thiols or thiophenols
to the quinone. It was found that they had similar cytotoxic activity than avarone but none of
them showed better antibacterial activity than avarone (Figure 50). The cytotoxicity was enhanced
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by electron-donating substituents that lowered the one-electron reduction potential; however,



































Figure 50. Structures of natural compounds used as starting material for the synthesis of several TQs. 
The structure of avarol (196) (Table 5) and avarone (139) (Table 1) inspired the research line 
developed at our laboratory for several years towards the chemo-induction of bioactivity on inactive 
abundant terpenoids with decalines that resembled those of the bioactive marine 
sesquiterpenylquinones. Thus, we designed and prepared several series of TQs/THQs, with 
variations in sizes and functionalities of both the quinone, BQ, NQ, or anthracenequinone (AQ), and 
the terpenoid (mono- or diterpene) moieties. As starting terpenoids, the monoterpene myrcene and 
the diterpenoid myrceocommunic acid were chosen, giving rise to two series of derivatives: 
monoterpenylquinones/HQs (MTQs/MTHQs) and diterpenylquinones/HQs (DTQs/DTHQs) as 
depicted in Schemes 1 and 2. Myrcene is commercially available, and myrceocommunic acid can be 
easily isolated in enough amount from the berries of Juniperus oxycedrus (Fam. Cupressaceae) [167]. 
Both terpenoids bear a conjugated diene that can serve as diene in Diels-Alder cycloadditions, 
the synthetic procedure used for the preparation of both series of meroterpenoids, using differently 
substituted p-BQs as dienophiles. 
The cycloadducts, either from myrcene (Scheme 1) or from myrceocommunic acid (Scheme 2), 
were stabilized as their acetates followed by aromatization yielding acetylated 
naphthohydroquinone (NHQ) derivatives [167,168]. Direct oxidation of the cycloadducts led to the 
corresponding 1,4-NQ derivatives. When monosubstituted p-BQs were used, mixtures of 
regioisomers were obtained in different ratios [169,170]. In addition, the change of the cycloaddition 
solvent from ethyl ether to dichloromethane, led to the corresponding 1,4-AQ derivatives as the 
result of the cycloalkylation of the naphthalene core by the prenyl chain. This cyclization was due to 
the presence of acid traces in the reaction, as shown by several mechanistic studies performed by us 
[171,172]. 
The size of the quinone was enlarged towards 9,10-AQs when 1,4-NQ was used as a dienophile 
[167,168] and it was also shortened to HQ derivatives by oxidative cleavage of the trisubstituted 
double bond in the dihydronaphthalene ring of the cycloadduct [173,174]. 
Also 1,2-NHQ derivatives were similarly obtained when o-BQ was used in the Diels-Alder 
cycloaddition [175,176]. 
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The structure of avarol (196) (Table 5) and avarone (139) (Table 1) inspired the research
line developed at our laboratory for several years towards the chemo-induction of bioactivity
on inactive abundant terpenoids with decalines that resembled those of the bioactive marine
sesquiterpenylquinones. Thus, we designed and prepared several series of TQs/THQs, with variations
in sizes and functionalities of both the quinone, BQ, NQ, or anthracenequinone (AQ), and the
terpenoid (mono- or diterpene) moieties. As starting terpenoids, the monoterpene myrcene and
the diterpenoid myrceocommunic acid were chosen, giving rise to two series of derivatives:
monoterpenylquinones/HQs (MTQs/MTHQs) and diterpenylquinones/HQs (DTQs/DTHQs) as
depicted in Schemes 1 and 2. Myrcene is commercially available, and myrceocommunic acid can be
easily isolated in enough amount from the berries of Juniperus oxycedrus (Fam. Cupressaceae) [167].
Both terpenoids bear a conjugated diene that can serve as diene in Diels-Alder cycloadditions,
the synthetic procedure used for the preparation of both series of meroterpenoids, using differently
substituted p-BQs as dienophiles.
The cycloadducts, either from myrcene (Scheme 1) or from myrceocommunic acid (Scheme 2),
were stabilized as their acetates followed by aromatization yielding acetylated naphthohydroquinone
(NHQ) derivatives [167,168]. Direct oxidation of the cycloadducts led to the corresponding 1,4-NQ
derivatives. When monosubstituted p-BQs were used, mixtures of regioisomers were obtained in
different ratios [169,170]. In addition, the change of the cycloaddition solvent from ethyl ether to
dichloromethane, led to the corresponding 1,4-AQ derivatives as the result of the cycloalkylation of
the naphthalene core by the prenyl chain. This cyclization was due to the presence of acid traces in the
reaction, as shown by several mechanistic studies performed by us [171,172].
The size of the quinone was enlarged towards 9,10-AQs when 1,4-NQ was used as a
dienophile [167,168] and it was also shortened to HQ derivatives by oxidative cleavage of the
trisubstituted double bond in the dihydronaphthalene ring of the cycloadduct [173,174].
Also 1,2-NHQ derivatives were similarly obtained when o-BQ was used in the Diels-Alder
cycloaddition [175,176].
These synthesized quinone/HQ derivatives were evaluated as cytotoxic against several tumoral
cell lines. All of them exhibited IC50 values at the micromolar level or below, improving the cytotoxicity
of the unsubstituted 1,4-NQ significantly, as the 1,4-NQ analogues were more potent than both
the corresponding 9,10-AQs and BQs, thus showing the importance of both nature and size of the
quinone/HQ systems and the presence of substituents on the quinone/HQ core. There were no
significant differences between the quinones and the corresponding acetylated HQs, and those derived
from the diterpenoid were slightly more potent that those derived from myrcene.
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Many derivatives were obtained by chemical transformations performed either on the quinone
ring or in the terpenoid fragment. For the terpenoid modifications, simple chemical transformations as
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hydrogenation, epoxidation and oxidative cleavage, isomerization, allylic reactions, rearrangements,
etc. of the double bonds were performed on both series of MTQs/MTHQs (Scheme 3) [175,177,178]
and DTQs/DTHQs (Scheme 4) [167,179]. No improvement of the cytotoxicity was observed for
MTQs/MTHQs, but better results were found for DTQs/DTHQs. Changes on the quinone system
included nucleophilic additions and substitution reactions using sulphur, nitrogen, and oxygen
nucleophiles [170] (Scheme 3). The biological assays showed an improvement of cytotoxicity
for those substituted at C-2, particularly for alkyl- or aryl-amino groups without differences
between regioisomers.
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Enlargement of the aromatic polycyclic system with fused-heterocycles, such as benzocarbazole,
benzacridine, or the benzofuran system among others, led to less potent analogues [180].
In addition, condensation reactions of MTQs with aldehydes led to 1,4- and 1,2-furoquinones,
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whose biological evaluation showed that 1,2-furoquinones were better cytotoxic than the corresponding
1,4-furoquinones [181]. Other heterocyclic derivatives included pyrrol and imidazole-fused
rings [182] (Figure 51).
Mar. Drugs 2018, 16, x FOR PEER REVIEW  41 of 52 
 
Enlargement of the aromatic polycyclic system with fused-heterocycles, such as 
benzocarbazole, benzacridine, or the benzofuran system among others, led to less potent analogues 
[180]. In addition, condensation reactions of MTQs with aldehydes led to 1,4- and 1,2-furoquinones, 
whose biological evaluation showed that 1,2-furoquinones were better cytotoxic than the 
corresponding 1,4-furoquinones [181]. Other heterocyclic derivatives included pyrrol and 
imidazole-f s d rings [182] (Figure 51). 
 
Figure 51. Structure of heterocyclic-fused MTQs. 
In addition to the antineoplastic cytotoxicity assays, several MTQs/MTHQs, either derived from 
1,4-NQs or 1,4-AQs, were evaluated as antifungal [182,183] and antiviral [182], with the finding that 
several heterocyclic derivatives showed antifungal MIC values in the low μM range against yeasts 
and filamentous fungi, and discrete anti-herpetic activity. The most recent and promising results 
include the evaluation of their anti-leishmanial activity [unpublished results]. 
Considering the potentiality of dual targeting in drug design and development, several 
quinone/HQ hybrids with nitrogen heterocycles [184,185] and with other biogenic compounds as 
aminoacids, purines [186] and cyclolignans [187] (Figure 52), were obtained and bioassayed. The 
latter were named as lignoditerpenylhydroquinones, and they showed a very interesting and 
selective cytotoxicity against the osteosarcoma cell line MG-63, which is a very aggressive cancer, 
opening a new perspective for its treatment [187]. 
 
Figure 52. Several hybrid derivatives of MTHQs and DTHQs. 
8. Concluding Remarks and Perspectives 
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In additi n to the antineoplastic cytotoxicity assays, several MTQs/MTHQs, either erived from
1,4-NQs or 1,4-AQs, wer e aluated as antifungal [182,183] and antiviral [182], with the finding that
sever l heterocyclic derivatives showed antifungal MIC values in the low µM range agai st yeasts and
filamentous fungi, and discrete anti-herpetic activity. The most recent and promising results include
the evaluation of their anti-leishmanial activity [unpublished results].
Considering the potentiality of dual targeting in drug design and development,
several quinone/HQ hybrids with nitrogen heterocycles [184,185] and with other biogenic
compounds as aminoacids, purines [186] and cyclolignans [187] (Figure 52), were obtained and
bioassayed. The latter were named as lignoditerpenylhydroquinones, and they showed a very
interesting and selective cytotoxicity against the osteosarcoma cell line MG-63, which is a very
aggressive cancer, opening a new perspective for its treatment [187].
Mar. Drugs 2018, 16, x FOR PEER REVIEW  41 of 52 
 
Enlargeme t of the aromatic p lycyclic system with fused-heterocycles, such as 
benzocarbazole, benzacridine, or the benzofuran system among others, led to less potent analogues 
[180]. In a dition, condensatio  reactions of MTQs with aldehydes led to 1,4- and 1,2-furoquinones, 
whose biological evaluation showed that 1,2-furoquinones were better cytotoxic than the 
corresponding 1,4-furoquinones [181]. Other heterocyclic derivatives included pyrrol and 
imidazole-fused rings [182] (Figure 51). 
 
Figure 51. Structure of heterocyclic-fused MTQs. 
In addition to the antineoplastic cytotoxicity assays, several MTQs/MTHQs, either derived from 
1,4-NQs or 1,4-AQs, were valuated as antifungal [182,183] and antiviral [182], with the fi ding that 
several heterocyclic erivatives showed antifungal MIC val es in the low μM range a ainst yeasts 
and filamentous fungi, and discrete anti-herpetic activity. The most recent and pro ising results 
include the evaluation of their anti-leishmanial activity [unpublished results]. 
Considering the potentialit  f dual targeting in drug design and development, several 
quinone/HQ hybrids with nitrogen heterocycles [184,185] and wit  other biogenic compounds as 
aminoacids, purines [186] and cyclolignans [187] (Figure 52), were obtained and bioassayed. The 
latter were named as lign diterpenylhydroquinones, and they showed a very interesting and 
selective cytotoxicity against the osteosarcoma cell line MG-63, which is a very aggressive cancer, 
opening a n w perspective for its treatment [187]. 
 
Figure 52. Several hybrid derivatives of MTHQs and DTHQs. 
8. Concluding Remarks and Perspectives 
The sea is an outstanding source f resources, ma y of them still unknown and mostl  
unexplored. It is worth noting the diversity of novel skelet ns and struct res of sec ndary 
metabolites from marine macro- an  micr -organisms, often incremented by their symbiosis. Many 
of these metabolites have a wide variety of biol gical properties, so they may be susceptible to direct 
therapeutic use, or they may be used as models to o tain improved analogues a d derivatives. 
In this review, marine secondary metabolites from mixed bioge etic origins that contain a 
quinone/HQ moiety linked to terpenoids are described, considering their marine sources and their 
biological properties. They have been isolated from a variety or marine organisms, mainly from 
Figure 52. Several hybrid derivatives of MTHQs and DTHQs.
8. Concluding Remarks and Perspectives
The sea is an outstanding source of resources, m y f them till unknown and mostly u explored.
It is wor h no ing the div rsity of novel skelet n and structures of s condary metabolite from marine
macr - and micro- rganisms, often incremented by their sy bio is. Many of the e metabolites have a
wide variety of biological properties, so they may be susceptible to direct therapeutic use, or they may
be used as models to obtain improved analogues and derivatives.
In this review, marine secondary metabolites from mixed biogenetic origins that contain a
quinone/HQ moiety linked to terpenoids are described, considering their marine sources and their
biological properties. They have been isolated from a variety or marine organisms, mainly from
sponges, ascidians, and marine-derived microorganisms, but also there are many examples of
compounds isolated from other organisms, such as algae or soft corals, most of them collected at
Mediterranean, Caribbean, Okinawan, Australian, and South China Seas.
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The found terpenoid fragments range from the simple isoprenyl chain, to monoterpenyl,
sesquiterpenyl, diterpenyl, and larger terpenyls. The largest group is the sesquiterpenyl derivatives
that can bear acyclic, monocyclic, or bicyclic sesquiterpenoid side chains. The bicyclic ones are mainly
derived from drimane, aureane, and avarane skeletons. The quinonic part is usually a BQ/HQ moiety,
and the corresponding cyclized chromanols, being NQ derivatives, are less frequent.
In these kinds of mixed biogenetic compounds, the hydrophilic quinone/HQ part can participate
in reversible and irreversible metabolic processes of oxidation, reduction, alkylation, etc., which are
fundamental for good cellular development and survival. It can also interact reversibly with other
biological targets by activating or antagonizing their responses and effects. Regarding the attached
terpenic part, essentially lipophilic, it can facilitate interactions with membranes and other lipidic
regions, and modulate the pharmacokinetics of potential quinonic drugs, and it can even interact
with other biotargets, depending on its degree of functionality and its polarity. This could explain the
diverse biological activities that have been described for TQs/THQs such as antitumor, antibacterial,
antifungal, antiplasmodial, anti-inflammatory, and anti-oxidant, among others, sometimes with very
promising results. Although it is difficult to compare the results of cytotoxicity assays performed with
different protocols, in general, those found for sesquiterpenyl derivatives are usually more potent than
those for compounds with smaller or larger prenyl fragments.
In summary, marine organisms still are a good source of new bioactive compounds that are
related to TQs; however, the small amount that is usually isolated limits considerably their potential
development as drug candidates. Thus, much research is currently devoted to developing good
synthetic procedures that allow larger quantities to be used for in vivo assays. The efforts should
not only be directed towards the natural compounds themselves, but also to their derivatives and
analogues, in order to obtain compounds that are more potent and selective than the original natural
product. In this sense, very good results have been obtained from accessible inactive diterpenoids
used as starting compounds in the synthesis towards new bioactive quinonic meroterpenoids.
Marine chemistry that is devoted to the isolation, structure assignment, transformation,
and synthesis of old and new compounds and their analogues, is currently well-established
in outstanding institutions of many countries, which are continuing the research on
developing new drugs of marine origin. Thus, to attain better profits from these resources,
further biochemical-biological-pharmacological assays focused on unresolved diseases, like central
nervous system-degenerative and orphan diseases, should be systematically implemented and applied
to evaluate most marine products. Similarly, the virtual computerized screening for prediction
and quantification of activity, toxicity, secondary effects and pharmacokinetics of compounds with
novel structures and skeletons, should take its part in marine compounds research, because today it
constitutes a very useful tool for the discovery and optimization of candidates to preclinical evaluation
and development of better drugs.
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